| Quick navigation: | Home | Site Map || References | Biography || Copyright | Other copyright | Contact us | Advert | | |
[ccp4bb] Another alternative to ChemDraw |
||
- Protein crystallographyMain steps:- Protein purification- Crystallisation Special:- Programs for crystallography- X-ray detectors Basic tutorials:- Chemistry- Protein - Peptide - Amino Acids Xtal community:- CCP4BB |
CCP4bb navigationCCP4bb <-- 1999 <-- November 1999 <-- 30 November 1999Subject: Another alternative to ChemDraw From: Peter J Stogios p {- dot -} stogios {- at -} UTORONTO {- dot -} CA Date: 2010-02-08 Coincidentally I was just doing this search myself today. I found a truly great program that is free and is platform-independent since it is based on Java! Enjoy.. http://www.chemaxon.com/product/marvin_land.html ~ Peter J Stogios, Ph.D. Research Fellow Structural Proteomics in Toronto University Health Network C.H. Best Institute 112 College Street, Room 70 Toronto, Ontario, Canada M5G 1L6 p: 416-978-4033 e: p.stogios@utoronto.ca w: www.uhnres.utoronto.ca/centres/proteomics On Feb-8-10, at 7:00 PM, CCP4BB automatic digest system wrote: > There are 19 messages totalling 3002 lines in this issue. > > Topics of the day: > > 1. Alternatives to ChemDraw 3D? > 2. Available Xray diffraction system > 3. Alternatives to ChemDraw 3D? Yes, Chemdoodle! > 4. transformation of cell > 5. Job advertisment: Head of Junior Research Group (tenure track) > 6. reforigin on 2FKA (3) > 7. refmac5 and spericity restraints > 8. Map transformation (3) > 9. refmac5 and sphericity restraints, 2nd attempt > 10. Sixth International Workshop on X-ray Radiation Damage to > Biological,Crystalline Samples, SSRL, 11th-13th March 2010. Registration > now open. > 11. problem of imosflm in ccp4 (2) > 12. coot and probe clash (3) > > ---------------------------------------------------------------------- > > Date: Mon, 8 Feb 2010 16:13:14 +0900 > From: Wataru Kagawa > Subject: Alternatives to ChemDraw 3D? > > Hi all, > > I would like to create a pdb file for a chemical compound (FW ~600) that = > was created in our chemistry department. ChemDraw 3D appears capable of = > doing this, but I would like to know if there are free alternatives that = > work great on Macs. Any info would be greatly appreciated. > > Thanks. > > Wataru > > > ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ > Wataru Kagawa, Ph. D. > Waseda University > Graduate School of Advanced Science & Engineering > 2-2 Wakamatsu-cho, Shinjuku-ku > Tokyo, Japan 162-8480 > tel. 03-5369-7369 (ext. 3241) > fax. 03-5367-2820 > ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ > > ------------------------------ > > Date: Mon, 8 Feb 2010 08:53:57 +0100 > From: Mattevi Andrea > Subject: Available Xray diffraction system > > Dear CCP4 Community, > > our laboratory is going to dismantle an in-house X-ray diffraction > instrumentation. It consists of a Rigaku RU-200 rotating anode, an > Osmic Blue confocal system, a RaxisIV++ detector, and an Oxford > cryostream cooling device. All instruments have been properly > maintained and are in good working conditions. > > If you are interested in this system, please contact me at the address below. > > Best regards, Andrea Mattevi > > > -- > Andrea Mattevi > Dept. Genetics and Microbiology > University of Pavia > Via Ferrata 1, 27100 Pavia > Italy > Tel. +39-0382-985525/985534 > Fax +39-0382-528496 > Web www.unipv.it/biocry > Email: andrea.mattevi@unipv.it > > ------------------------------ > > Date: Mon, 8 Feb 2010 12:33:45 +0100 > From: mesters > Subject: Re: Alternatives to ChemDraw 3D? Yes, Chemdoodle! > > Alternatives to ChemDraw 3D? Yes, ChemDoodle! > > I installed XDrawChem on Mac OSX 10.4.11 but it crashes all the time=20 > which is somewhat annoying. > > Then I finally stumbled upon ChemDoodle *which is not for free* but the=20 > trial version solved my problem at that time. > Having worked with it, I really liked it so much that I finally=20 > purchased it for 60 US$. > > You only pay this amount once, software updates are for free. > > Hope this helps. > > - Jeroen - > > Wataru Kagawa wrote: >> Hi all, >> >> I would like to create a pdb file for a chemical compound (FW ~600) tha= > t was created in our chemistry department. ChemDraw 3D appears capable of= > doing this, but I would like to know if there are free alternatives that= > work great on Macs. Any info would be greatly appreciated. >> >> Thanks. >> >> Wataru >> >> >> ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ >> Wataru Kagawa, Ph. D. >> Waseda University >> Graduate School of Advanced Science & Engineering >> 2-2 Wakamatsu-cho, Shinjuku-ku >> Tokyo, Japan 162-8480 >> tel. 03-5369-7369 (ext. 3241) >> fax. 03-5367-2820 >> ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ >> =20 > > > --=20 > Dr. Jeroen R. Mesters > Gruppenleiter Strukturelle Neurobiologie und Kristallogenese > Institut f=FCr Biochemie, Universit=E4t zu L=FCbeck > Zentrum f=FCr Medizinische Struktur- und Zellbiologie > Ratzeburger Allee 160, D-23538 L=FCbeck > Tel: +49-451-5004065, Fax: +49-451-5004068 > Http://www.biochem.uni-luebeck.de > Http://www.iobcr.org > Http://www.selfish-brain.org > Http://www.opticryst.org > -- > If you can look into the seeds of time and say > which grain will grow and which will not - speak then to me (Macbeth) > -- > > ------------------------------ > > Date: Mon, 8 Feb 2010 12:34:13 +0100 > From: siva charan > Subject: transformation of cell > > Dear All, > > Is there a way to transform a cell in Pymol? I want to superimpose cells > of my two crystal forms, when I use the align command, molecule from one > unit cell transforms on to other, but the cell stays the same. I just > want to look if by any chance my cells of two different crystal forms > are related!! > > Thanks > Siva > > ------------------------------ > > Date: Mon, 8 Feb 2010 12:39:54 +0100 > From: Christine Bentz > Subject: Job advertisment: Head of Junior Research Group (tenure track) > > This is a multi-part message in MIME format. > --------------040300030302050604070200 > Content-Type: text/plain; charset=ISO-8859-15; format=flowed > Content-Transfer-Encoding: 7bit > > * > _Job Advertisement _ > > *The Division of Structural Biology at the Helmholtz Centre for > Infection Research > in Braunschweig/Germany invites applications for the position of a > *Head of Junior Research Group (tenure track)* > > Area of research: > Structural biology > > Application: > The applicants should provide a letter of intent, CV, list of > publications, list of certificates as well as a short research proposal > (max. 3 pages). > > Prerequisites: > This call aims for top level postdoctoral fellows, 2 - 5 years after > they have been conferred their doctorate (child-rearing periods will be > taken into consideration) who would like to participate in the Helmholtz > young investigator program (www.helmholtz.de). The candidates must have > completed a continuous 6-month research period abroad during a doctorate > or a post-doctorate phase. The most important selection criterion is the > outstanding quality of the applicants. > > Funding: > Position of group leader, scientific/technical staff plus expenses of > materials, supplies and investments for 5 years. > > For further information please contact > Prof. Dr. Dirk Heinz, Division of Structural Biology, > Helmholtz Centre for Infection Research, Braunschweig/Germany, > dirk.heinz@helmholtz-hzi.de, phone: +49-(0)531-6181-7000 > > and visit our homepage www.helmholtz-hzi.de/en/research/research_groups/ > structural_biology/ > > Please contact us if you have any questions! > > > active_dimer_side > > > -------------------------------------------------------- > > Christine Bentz > Assistant to Prof. Dr. Dirk Heinz > Division of Structural Biology > > Helmholtz Centre for Infection Research > Inhoffenstrasse 7 > 38124 Braunschweig / Germany > > Fon 0049 (0)531.6181.7002 > Fax 0049 (0)531.6181.7099 > > -------------------------------------------------------- > > Protect the environment - > please don't print this e-mail unless you really need to > > > --------------040300030302050604070200 > Content-Type: multipart/related; > boundary="------------000701070601060606090904" > > > --------------000701070601060606090904 > Content-Type: text/html; charset=ISO-8859-15 > Content-Transfer-Encoding: quoted-printable > > > > > > > > Job Advertisement > > The Division of Structural Biology at the Helmholtz Centre for > Infection Research > in Braunschweig/Germany invites applications for the position of a > Head of Junior Research Group (tenure track) > > Area of research:=A0=A0=A0=A0=A0=A0=A0=A0 > Structural biology > > Application:=A0=A0=A0 > The applicants should provide a letter of intent, CV, list of > publications, list of certificates as well as a short research proposal > (max. 3 pages). > > Prerequisites:=A0=A0=A0 > This call aims for top level postdoctoral fellows, 2 - 5 years after > they have been conferred their doctorate (child-rearing periods will be > taken into consideration) who would like to participate in the > Helmholtz young investigator program ( > d" href=3D"http://www.helmholtz.de">www.helmholtz.de). The candidates= > > must have completed a continuous 6-month research period abroad during > a doctorate or a post-doctorate phase. The most important selection > criterion is the outstanding quality of the applicants. > > Funding:=A0=A0=A0 =A0=A0=A0 > Position of group leader, scientific/technical staff plus expenses of > materials, supplies and investments for 5 years. > > For further information please contact > Prof. Dr. Dirk Heinz, Division of Structural Biology, > Helmholtz Centre for Infection Research, Braunschweig/Germany, > > -hzi.de">dirk.heinz@helmholtz-hzi.de, phone: +49-(0)531-6181-7000 >> > > and visit our homepage > > /en/research/research_groups/">www.helmholtz-hzi.de/en/research/research_= > groups/ structural_biology/ > > Please contact us if you have any questions! > > > > src=3D"cid:part1.07000509.05090207@helmholtz-hzi.de" > alt=3D"active_dimer_side" v:shapes=3D"Bild_x0020_1" align=3D"left" > height=3D"254" hspace=3D"12" width=3D"314"> > > -------------------------------------------------------- > > Christine Bentz > Assistant to Prof. Dr. Dirk Heinz > Division of Structural Biology=20 > > Helmholtz Centre for Infection Research > Inhoffenstrasse 7 > 38124 Braunschweig / Germany > > Fon 0049 (0)531.6181.7002 > Fax 0049 (0)531.6181.7099 > > -------------------------------------------------------- > > Protect the environment -=20 > please don't print this e-mail unless you really need to > > > > --------------000701070601060606090904 > Content-Type: image/gif; > name="clip_image002.gif" > Content-Transfer-Encoding: base64 > Content-ID: > Content-Disposition: inline; > filename="clip_image002.gif" > > R0lGODdhOgH+AHcAACH+GlNvZnR3YXJlOiBNaWNyb3NvZnQgT2ZmaWNlACwAAAAAOgH+AIf/ > ///mxa3FjFL33s69WgD/7+b/9/eUYzH37+/WtYzm3s7FaxCUa1Jzc8XezubmtYytWgjezsXW > va29vd7m1rWtSgCEhOZzc+a1a0recyn3797enGPmzmOtnL29cym9hELv7//ecwjvlDr3ewDe > pYy1nJxjQhm9lHOc5ube3uaMQgDWYwCEhK3m7++lnN6ttebWrXPWjDpzY4T3jBCEhMWUlNbF > zuatY3trY8UZ3nsZ3jEZnHsZnDHmrWuUYxDma1rmc5ytazFjSlJjYxmthFrmxRDe3veMjGuU > va295mvmQlrmQhkxGRCM72uU761KEIylrd7WlFoZMYyMQkLvxZQxWlJrnK1SY95aGTHv3t69 > 3q1KSpy9QkqUlMVr3uZa3nta3jEp3uZanHtanDFrnOYpnOYpY4wxWhlr3q0p3q0pnK1KnK1K > 3uYI3uZKnOYInOYIY4xK3q0I3q0InK2UlO+MGQjFjEKUY9ZaY721MZRaY6VSUrWUlDq9lBmU > lBBaKQhja1K9GRC9vfdzc6VKSoRzWqXenFKMShDFtZxaEAjFpXutjHuUlK1SY4RCMZTvawBz > MQCEOs4ZEO+EEM4ZEMWEEITexZT31rXmzjoxKVIp3lop3hApnFopnBDWnGsI3loI3hAInFoI > nBBCOnu9tb1rY+bvrTqM7zqMxTqM7xCMxRC9Y87mnM61Os5KEO+9EDrmc861EM5KEMWUEDq1 > EITelBkQKUq9lOacY5zmQu/mQq3mEO/mEK3mEGvmECmMvXvmQs7mQozmEM7mEIzmEErmEAiM > vVpaKVoQCBC9Y6UpY++EOu8ZMe+EEO8ZMcUpY8WEEKUQKRkZEJwQa1Ja71pa7xBarVparRAQ > axmEMYQQCFJjCFoIY+8IY8UZEHsQSlJazlpazhBajFpajBAQShm9tYTm77Xm93u9tWPm9xm9 > 7zq9xTq97xC9xRC9Y+/mnO+1Ou9KMe+9EFrmc++1EO9KMcWUEFq1EKWEMaVSUt4xCFLm70rF > 7+aUvea9Wgj/7/8I/wABCBxIsKDBgwgTKlzIsKHDhxAjSpxIsaLFixgzatzIsaPHjyBDihxJ > sqTJkyhTqlzJsqXLlzBjypxJs6bNmzhz6tzJs6fPn0CDCh1KtKjRo0iTKl3KtKnTp1CjSp1K > tarVq1izat3KtavXr2DDih1LtqzZs2jTql3Ltq3bt3Djyp27EQTdu09bsOiSImqKvXbxrtXQ > ZVBfpyn0DCIluC2UFDQOG/xnQ/LMFC0WQmnQuK0NFwBSvAhckNSgDo9j/oPCQoaeCQltFOrS > mW2Nwy8sA5hgwwajFh1owGwhQwapFl1oI6QBpQvp2mYhD7QhqCAUxjZodCFlo4sNlSDCA/+Q > wQKAjQYOEEI24B062gnVBTqATbCLEQAGBg3aPqELlJMGQKHfflBU0UUNNHx3ECm0ZeeeWS3U > QBoINRCEXGApIHGfQKmVZFoLIJLCiAxbtDDBCwgthh8NWTxIlg3/EQRFiwKloJxARjj3T2jx > kRRZQTTABoJzBhmgR2YAQIGii2KRQt9AUCi4W4wDpQCFBROAIKVINk4HQn8C/UPDhgSRIpx8 > 5TEZFmRICgRCBwMJ8qRAgtDQgAVZbBmSDRWah0MDDZDWXkFd0GfAiGqKBUV69dHXoZs0WNAA > DYLoCdIEfdKwxR44SDlolRYIpBcglia6VRZ9CmTAXy0uat2kgPb/KBKDoRWyxaZHCjQBlRzG > GIEezxlVgAIGmEoRhcFOoGGWBTkAqJ2MjtRlF7fu0Qicut6IHwuM0sAYUgpEEYMHhhhChQbG > RtQdQcVOMMGZBdUAqB6yijSIDXrcugUh0dI60Lt2tUBDsENZ4gEMKWgQgSUbeLABulVpQEEA > CVChQEcFHFRABBVbEsDFCRWQoEEu4NDmv3oUogevIrFg662EwAuAmcWGZsFhXSxpVMM0EpSF > J3ZAHFUBFAcwgAIKPBBAxhlpgAgiEWRRgMQBkGCJAllkQQEJEijUZUE24FDDBCdDoRgOY5aU > QiP6EmIZI9gCMChkBAelSBQ1H3SCIVIV/2BJBEwPRHHgF2mggCUSBBDA1XmLmnjjBIFAw8kA > OHCBBRbU4CmggzRQL0g2tJ3mQCzAJkgDN0LBslCIxFD3QArYsSNUCiCCEAWWHNSCAkJ3FAHI > BZkY5Mkg3Bnpj6HhMIjKNcxuLyEw69ZFpHiU8i0ANfS8kwYJKILBByRALEDuCmVhCORMZWE7 > Qg8QDoAEVpMQQO8buS9qynvQEPh5mNNAQ7Rma4AeLEAm0LVNZiCoEw6qZzI3WaAFr5uJBk4Q > BAF0rxwC+MAAAPAB7R2EAoaIIFL+YQn6Ca53tQvM4ShwkkHkaxCBKQALLtCF/j0QSjiQAQ4+ > 1xFqQc9tBDnPFf9wUAo8CGc1ksLBnGyiAA+cAF2kiYAHJPABhiCiHFOJQNcOcokNnpAgBaCC > /T4CApVtYXK6wsEFJhWpBkBhdi0QoB7oIBIH7GtfMqvcBdS4QCgYoAU4yEcgl0gTDXxgfQZR > hAcEwBBLUGEq3EPIuQgStYJEgIURaQH61HOY5ekhV5JrwAWgUCf/uVFVZpPBBQrYQ+jtyzI2 > 2GMp1LiH7xQPBzjYAyFnkoANJKQFGQQeQhwJEQ0MwHA/IRr6FPBISgagIP+ggvMcgohnNqQw > UNAL9ArRl7BZ4AKjkZedRlYrQgyChxlpQSMcQQhH8AoEFqheA66AhwZkBgQLxAMe0Dn/HA94 > EIw9iIIiFmIJGCzEAAgtaBTs8IEPjG84FLgEBSgwRgBQQXsGGMADPNiCEjbuYxGJwPwYMqQC > kAIKNGjEJzFDgwu49ALhEScOCAgAQFZhC6P5CCnYOYpCtKkFFsAlDq4wmxjhEw+DPAnlFjIA > AWxSIFmIggKCsAGKIoQEBtVdOYiAAQF4YAGGuNg/WiCBIHjiqSRR2AkiIDEKSECYA6ECkgZA > BSqM1CAUSIDiKIAuDViskggpwIQkxhB3CaQAg9hCI2jwDyNc7psXgI0D7KQfOoBAL4UQAh1Y > qZFBjGIUZngSUInYgFJsAQkg2BAg8cCpOdkIrRaJgAlO8BBF//RAIQm4bRYUIQA7wMB+iMhq > QQrAgClIIAIRCEIPPGEIGFxCVALgG0qGZYkEnOAEWwQA0eDaAioUKwAWe2oBKLAwrAWArxFg > wAk8cV5haiAAErgaQe4aGylBgRCNCFSSXIq5+EBGMYWgg+oiMIpzesQGn42Z8+iAyys0gFOC > EMQL4kODPVi4R5AZxVIxEoEDlIABROirBMoBWAv5MyEaiAEFkkYCKlDgBFFwHyKqaJAPIwmE > dkmBwR7gJg9YsyS4IwHWJGAAEpzMaAQZwDM1wGOFUKBYVKOYIgIQAd7CYGKYVICQW6CBEg7k > vQsBgc5IAb0f0eECLb2eeVjwSRfCxv8KjRCECCfCgkyMYg+S6QIuS9GAfAyCDnTA3IYqvIVO > AQAEKJ2ADEplkRZ4AIstOMEl0nsAITDgAL3TgACEa5AmbmADMdgAbzfwDwFEwJIfmKZAjrBF > ENihmTUKAiYlEAOTXIIENFqxAhLQOAOAVCC4AwAzFTLegRhAAcgVaQIoAAMSCOQSAfC10LLw > YwDQd7gKoIALAjMB/DaAN5LaI8sc0BpbVccBQqDpRlIwikwUOj41WGAR92CfM39TQZraAkyz > Q6TtdCQAtcaPBjQQhC0mAAJ2EIAiLOGJIND2IMf+6sGQBAIMMDwBBcnCB4DLSAD0oAeUQwQG > iuXoinKEAnL/HUgXHwBX/ExS2M8sAMYTogAvHmRxD+gB0zyGybgKbcUH4Z7HOnDqmRGCEPax > k0tRpxsQsECxY3K65ziCBDuT4TwpqIE+F7gHRgDAsS+Nz9O3MCk9KKgFhumIIVg4Ywz4AAJR > oEIUIDBlRJyACIoout+wSoIMMtQDJyYIFQM/EER0PHhBCIAipFsQEDDgmQrAAEm21jhmwxqa > lshYGDNGsYRcwoTGjoAneoBJDfy2IAPoWbGDl4At2qAEz7RBIwiBp5YC6k/MadOQWEAIIXRB > k1Cgg6otMohM1NIAYQvkArdAJBCc+QKliFEDfsiCnkmnLhrAmwQOEAEQEAEREoAA/wEGehAF > xEDhilgEdlfsgZYbQLkGsSBCJOADD4AeAOWgLQOwKJIWgLwgzDZ8sGNNWWAxA9ADCWBCq0dz > UeAJC6c1JOA+18ZCCkNlW5NdWQAFAfAAEiADMdMCUKBGzyIpFvAYQ/IdpNAIo8AYzsdoEpEF > 7YYDxdIFe6AHubQHfuRApeBS8dEBe1Boz7Er/4YOCnAANHICeuUBEHB5AwFC1TYQEsB4BJEA > C8BpwuYBFSUBKsCEBGF3i8AAsJURE2MQVBCBCrE4GkA0o/cAArABVHBMA6cA12YQGuAJUdBb > H3BREwVGlpA3LWBdDAA0HhADdmAImQcAFMAIgrBrhDAKNP8QARPwJw2ANhbgP/7jH1CQYywg > BKMhCDd0EQGSCXqQAuxRgxa2BxHQOHRQCnRgA4EhOaPQAAVETgQRUS3nEBUjfwLRRDFAiDEA > OQWwdgihCFYIAJZgCLRWLAZQgB7AhQIhAYdABJ6QEPsXBLfYEUdTEEy2hwohUpbgVgpQABLA > XD0gPwFwCSZXU99zAh5gB1FQdNWGNMJmCSTgCZVmO34lAvoYA56wIxHgHVkwe81jNrh0IMcz > TjSwH3ZhAKQgA4ViWRiRH3ogEDQAPRamH1BQQBJmBEYQHjmmb6QhMCcDQucXA00GEQYQBZbQ > QQShCAsQA6J3WwQBA84oEDEAV03/dDEC8HFRsAAE0AdREAUJ6CYKoAjcFwAfUDcSwAAC8IQg > EVHDBQNg1hBZcDEUMAAUEFA98HIKUYTI1VAesEEKAAOixkIScDeAVwu9KABCc4wiYAgx4GwA > kAWMAAUeaFl6ZoN9gSldwEawMigtgAQHskvq4jZoNwq4kokt8AJBcmhGEGEc2ZEtkAKMsAUW > QBoTABpNGAPWpAE9cD4Q0QJ9wI4PJyo+aWoe0HMFlRBU0AOqRpMAYHoE4AknQACGkAUtEAC9 > 1QO9tUjoIpS6wwDEaBLUZhAR8ADh0xAsdAkXYwDnsAGGsFwScH8CEQB2oAgUIAACgAHg1YAc > kACekACX/6YIJGAI+qiPtykQEQADpgCXbCkQGsAIs7dtcqRf1PEZlggokyIlyOGCD6EY6oSY > eHAbBGEjEhZhghCZKTABdbYFVCIwPUMBN0kQTWQI1zVlwFMA9hMB/hAEPoBIABABK0AAEEAB > iNCMlmAJPZBpAzAshhA0BdFE6CICK1B/EBACdvVxQLMBrdcidWgHCBEAQlmMIeFdBjEA5DmU > KFZz0SYQrdmAAeUJRXcQPQADDDOIQaCSLUAB52AOAXAAB3AEz9YDprCPMTaXGwiXH0B+2nWX > KZBYOKAcLoAkKcBG0zM9E7AjRlAD/OQQApMCO7UHFtAj/3CgL0AHLzBhCNoFHf8AHMZHR4dW > AzoTAIZgcxEwd5AACRUACAfwdgJwluenCMJkCT4wBR/QcwAAAwSwqo+0nkSgpGRlBxBQAe0I > A8NXDiMwAAMwAirwBzcaA9FJAhNFAh+QVQFwMBV1ZQFApCDBlZS0pcmJEAoAbQRhDp85ejCw > XAmwVFRgByfwDxFgBx4QBORjDlTAAYYQBAeQABljDiJApvo4RdrVYueHAYtAELznAoLwSUoU > GrxiA1kAAn9UU7viAHwxAZwFEQZbpxaQU3ECaIB2qAhaA/lSHVW3B3RUp4JANBEAncBjCQtQ > AZBgAiVgBxMzqySaqRhwAr51lSQAphSQAoYAMSDwAQT/MKLTWH4mYAIHcHc5axAMMAMDYAoi > CwEj4IwpEAR6BZMKEQWXkAIxQJ2+45QAgAhW2QPoM151VRDmwAGewFzg9WlXBkbpGmJZ4HfN > dAnn0AMe8AEewF4oR6bmSYgfcDERcAIfgAEMMKUA8HQvQAr5ggP3wScMUSd9MR8XYSefIwgX > ALERSwc0UAhHtwV01AHuJmfMgR/2yK6wEwIEoAJD0Bck4JM+AAk3qwJHQAQLoAgJkAAPAAMH > 4AECUQ4cUJ0Q0AerugKoCk1QtXEGAQImMAI9sABDsAAzUJPCFru7axDCKI0KcVwaMYYGQVYT > ZS66ipV7BThslWRlGAXN5Vc9/7ABzjUQD5C3GGC1H1CIz2UAdVWm50cCPQBe7psBDIUBy1a1 > 33cyaNcILtAFjVAIZ/IZhdV82jIRkQI5guC4EDspERA6t0JHXWALO6Q6+OEmBWEII3oIRRcF > q6oCkBAEnpsANTubSBIAPhA0LQADBkABQeABPUAAnhu1CwFMJhQBf2C8tWAKznoQROABYRgF > FMgA5BM8iwAIwll+4fgQ/1AO96cw0dUDNacALRA4W0oQnpkAZGkIzhYAGxC+3qUBdvA9RAAD > CYAB5nlbHcUBn3l+hlOG4+K24woIWWAJLUIwWZAyUNABd7YkWbcQKSAIX/MoEgEj2YEhFZYP > 0FcKFv9ABwBcM3pwdDCFCLbgOWgUWCGwAhXwcArgkwRgAovwASuwAkHwRz6ZVYjwqu0HA4oQ > BAQwA6oayrbJENFaJkywAqZgCsxaEEr4MLiFSaQQBEtFBGKaBUFQjAlQAhuWEBEAogbBsjpn > EAVwCRiFgBQwelVlbV28ARvIUHzgbCsZAx8nKgmgxk05EAUANHl7AEFgO8V5EPuKA3TgWbJI > J4Q5ECc1M4/BAroBES7QFwdiHjXQBYwAN0jgMsxBJXXmCIESwXxawAVhCaEMAevzwrN6Ag9w > owQwyh63qhfDALbDMLJ6sx5AAjDsuQSAvPhhCPZzBJBgCrXgA3yLEKpKAB//AM73V00CkQCy > WxD5NztTJYGHCBGI8416gwFREL/TWnPMaT8ccAItUJ7imzEUYFsfhwFE8AGnBgKeoI/PjIh1 > tVxTGgF6C2Lkx76QowEG0AF60AB0oFirxCHRghAtwAi00R8lEIYJYSWoNCn/VCwRQCVQ0G4w > VQKZ4AKVGEGKAAEjOmVUsADiV389oAgrAAFBgC4UMKKfegBIIgC5SwC1INkh4LkrsADXiB8w > WhCeUAshAAkMwBCbPKIXpQiFiIB1dV6e2QOXAAOpmXEeoHuecJK7qM1dCU2IwFAC4EEFgLdE > wJkakAVpWBAZ5VYP8I51+GnNRAFdnEF5ezEt4AnA/2oKXuR/52AInaqdnuC2doDbJznEFQg1 > jLDWFiAEGHtoL6CZB/V7FVwRNvAkoZPMNaVfoTEK31AKRsAImcBgOLDPTbiqEOABq6wCqzpF > IMDBPgDMwua5KsB92gWyih3KDk4AI2DSBPCL0iqFsdkDM/C5kEC1BREDq0oABuU38JOtMAAD > dtAHIRDZnPvQcik4UZBxH3CmByEBJ+Axn2cAGrABQSkAnkA/EmDVdvBc5WfbP2MHH+0JXexF > EdADePs9fQgC5RkF78o0QgoBO3sIC7ACIVALGTADhvCzH7PC51UACJUCrmEBWzBHu+KKDfEl > /v0QHUAfNiADjbAQmNIXBv8gA5mwQyVQBRegB/mgM+UXAyrgA3d3ADgrbBAAASpABAJBAiP6 > AfC1AeKK0aEcA6A9ApMdyjE9ELkFhT08Aj6gApT95wDwADc7onyTBUDKLjPw66ZgDroTlgBo > 4gDgCe3HLoZDMVvqjl28gXfYW7YqKgXQAt7zAQ+wTGLkJlF4AlXJXDzahAIApgegCA/AbIDn > AecuEC7poYfAABRgCr8+AxkQAk2eGdzDVwYxCKqkB5SSAnM2ECDonw/RmOxWfQNcA1DQCMYn > CAaeS4WQKghhSIvQswdA6w7noZn6O4bA6VCTQXQcfqGc5lwO4mueu1TbAiIAMbwVA7wKCSug > AjP/lxAUkOa5u9N5SBCmMAK/LrzGhh+XMC6Q07rTGwCeoKtySAV6tTQCccra2YYw4FDayWsp > wADFWg4fQARRYHOHlXKHRQEPYL+LM3rCKBBc1Vss163ASr9dYwAxsABfFQQxIDW3LAK/Xgse > 09wJQGIrljfv7VmXCRFyohERMAitUegP0RssYAtbIAhIcGcWFvgoxlC9+gcMUPl/kPklYAkQ > AAmHwJ0LkJRmrwKifZNEsAIj8AimwMEr0OsFUeOxKb4o7sGh7AOlvYseMKKeCwEXQwI/Dp8z > MALCL7Tw+WoiIPxg1QPnfgkPIMMHgQhALFH2k9xEUP3fgwFWrZ2XsH0S/5BB1W8HwC1sfAsC > 6xkFTl0AivBpz5wFBxDkbbg0GOABprABL1lzv54BGbAA72ptt3z/D0BWAJGgQAsFCgIEoAAA > ACkcOBrRUfivRYt/Ci1eBDBhAkaOHT0CAGGjhI0uUD56dGBrFJ0OjvRs2dPAyMcsdhb4gPQn > AoAIhyDl9KFIxYEILeysULFIIQkVBFaEIGAnio8VI0b0COB0gQaMAWJoKCAgAZURFaYYCuEj > yEmFBWKsWEGAACQiAFp4GKBQhNUZVxVm+aBixCOrMCiQ8GTHUJQsJxUpOKlAAJEPDIicEPAB > A5Eeihi0AEHCjgcihrhapAD5ogEKdohAjrBhA/9WABoYCBBgp0eCACcwfBARIwSMSyJEzKg1 > w5QpDRSOHw8Ro3aCxhZZBxhIQ88eQQBSQBE0AcrGjim6VGSbvmMLGuQxTgTB0UAmQnQGNdqS > X+ZHtAsgQEIEpNpm6AupIFIAgAIIVDBBgxZOWBCqFQwBoSerRmBuAaeosKgAS2II4B8BqLik > LEgoMAQpQwxgywANFwhhBTsYUMiTHgAY4EKrEgIAkaYufOQS9S46jEWPFEignMksOyIzy3o4 > 4QQWA/AgiA8CuCgLITEyoAcBAjQggdl6KEABK6MYMQAGPvjAkOAy8KCH5WYQIQNTROjhkggy > CCGDDBawJIuDqrNoACr/FKhBDxwEISkFFluAgpSOoEBwSEstyoIGRsMzAoQJOuhCvBQ6TYFR > GVbSjhBCFv2Igr4W6KMu6zggcAUfPDBAgwNUgISoA3yAAIKnCOAQACIuvDEGAkKIQiFL7Iih > sQgEuGSGuRBRYAQIfCj2JApWCBYCQGXVIIYCeiBsMDssekCFp9JV7dJ4OdIgABAKgCEFRBZh > 4AgiYsBAgM5OsIQCATyA4CvrsOPIkg9O4CqCKKKIwY4PFvDAgygKsA2RAIyL4U1T6KRzOVOo > aEE4DxY4hAgQAqj3tA4vYaSQBmqAwgYHjEihBQOgMAmjDuK79FIQamhAEFJIamCC+F6ggYYu > /26ewIZT6ZgAh1FGuWCmjgygdYQVFiBUISr6gqCCES45gVcVgjCBiJuWfSqvFg640BQAEtCK > gh4M4RGAADawFpJFNBABqT5k/qgHAiB4fIEPmgXpAypqgQsuCcxewN0YCfCgaIuaoyCvi6jg > SgEeQdD3CGjtsONQCRTxJIgDDlDkItU5MliAzan0IIYoMDgAYQ8SiiBXNzOIwRABFsA4g5J7 > oKIADCA44BAThvhHgQgKQIgjhix4wYUaaLiggQZs+Hk8pQURpAavRU8vhQamDtUBKLroAAAb > bqZBA6DQPwAwIhN0eMEeMrEFOhCNIwroywhCAAFzYKQHEvxR51QwlP8U2IEDN4FLdHrQAwlA > YAR9uREFnBICQ1gCIxSIEV3uAi4IiEA9yhJWCCxhiQVABgQeyEAIZWSXQxDAByqI0QIUsTnR > aYAEqQkAFUqnAAnwiETveQDIYvAABYAmAR+4XdlSA4CBtMUTAlCEIsRiox4wIAgY8EDxmsOV > HoQsZCtDWA1FYArqZUELUxjCFEzwmQIECBGmsYgRBog+AWZqfw2gQRa6gIOo7WEPeMBB0xxI > v/LczAYToAEUBuEzoNWgC0ybQBdekAIbHJAOCtzCCz4SgAuBKwgWe6IGPDACAiBxBEfc4Ako > YIpzaChGIaAACBxGAAIppzbGRAdHLqgCGs3/kCp6S88MaBgCrhBhXQqAUQgJgCVLqOAPfxAW > BOxlEQV4QhEtSE+Y4lUACliCBPESCEeKE7LgGAIGlkAEBjDgAxd2CCGIQISRSCCAIAhgIorY > QBQO8AErBcEDVCgKAKjwJv/gxAR/CMIeTXGJSwxAA54whCE8kYWCSAADLcyCBsyDCBC4ICY2 > cEEXuoC0TAriOzRwQQuy1gAcdIGVZeOk/2hgA4WkQFNbQJAGIOmC8HQhlIU4XxUuYJ9MXKE7 > HknAU4DJqzNGoQ9O2dYI3OYDHxiMD5jw3IQsgggINJNDBfAAARZgCAuqlXsAMEAtCFCBEHTL > Iy0QwAoh0AcWSWCc/9CSC1TWZQl/9NJdBMgdamLgCQbEq14d0YBhQQuDjhRgAyEzhPBGaIgT > BKGhpmMnKSRwmmkFIXdZUAQMokBRigbMExIoAI5iELIgBPII/NqjcThwiQAo4AEpjcITAXCE > K5FgLF2QAItoYDML0MAiKWgIi7JGNKfSoCFAgwI8kwoCqSnEBgHUziAmUANRZQEKkjTl1Aph > ATrQYAsWCFpHyrmgDapgCCBAcBQeJ6wVQGJBFQhCCzYAxmXFqFuICMHIZsABkCiYALUIrkKq > pYJDRIErl4CKCbdEExNAwikE6AMMpAi9HnggLnKhQATSBjm9KoYKAxjc8QCwiJ1o1BAfyP+s > 7gLnEQkwUZrBCU4UNjCAASQAAgFLQEcGsCUNYMAEAlBAFhBho91W9AMObUtwhusxrgzAOCIw > BPUMcInn4ibLACjBIugrAUTUgJU0wOTU5BcfKNBgEC/I2iCYqtSbJS0j7qHfBAohS0EUAgel > ygIkU+AAG/zjBTlLpRHeO4oGXGBqFugAaMpziHPm5A+HWBKr/+CubVVgQVjqARGQGCMQW6Qc > fVCOcvISBcgtIMQFmEEFDpGCCHzFcZCbAWw9oqtgNUVyHxiNB2DwOLm0cIM+qAABYgCZAOTG > Dg8I8SLKoYAN2EEDWTgA4wBwiSV3ZBGkaA5HDCWCKBhHN36j6Jr/6o2jwCnCBIeAQQskcIIR > 8ta1BQUsxUTgAUXQMwJUuJNx+CikFpzRDqQVCZEFAQUL3C+Ajb4vyaU2kQZsAQoa6AIpgGYD > KCCtBgrxMyfbp5EG6MEkE2iBDQbxHZKQYtOprIENSNGIC2SSBh1oT3jUe5EUlKAER3hbAiKw > dS0wgAEDbUoFgBXcBByCx2MTAFdAIIDlFMEUGALAtuGypRT4hIleycDjVhBttrRgBo+IEQQ4 > oIH4lDlcIWibCsK9AjKdJAIHsEM+jTWvBEm7IxEohyE8sOKLPCBkFPuAB54YgyAc4gQhNqhF > qHQIBnCFArM52G8gAHEDpDYGZy7AP7IA/4M3x7kHpoMBblYKhShklqhENbTU9NAFhUzEIuyB > JwhaUB3xQKEB8ZnAV+l3SvO2x70OAEAHBiGIDsjSIp7CmR4usB1IhqoFpZq67gzxACNhBASH > aEovSaAQBeQ/BCEIgHIIggJYO0wwGQnSAEtAqzsLPi1ADwB4gBv7v0r5iEuoiv/rg8EDrM1a > EMjBiaZYAREQrcNCPQD4AMr7nvSAASCyg4H7hzq6oyBIgBZQhDg6ACezCNRpPkUIAhU4AYWI > AIj6gFqIgRK7iARgngz4ABeKgCx6sytSiADYDEOQOdbynz2QAVGCgheogUwapUnRPosQFRyA > p+9IqpwiqqRTCP/9ab796Yiq6YCmQ4JMuh+myoIwNBsQ+QgfUQEfAJ3TQIQKC4ERMAcQIIoW > MARMUERMGIENAADHihHpUIAbwYiwiqytYIsLqooViAIKmBKEATeccLAREMH6uxTbkDf1UIDb > Y8WB0wA3Cb0PIIIEoIAqOQAMkDeDsIgEiIJDIAr+g4GBwhg7iBcqgBY28YQIUIDiMA5PUIBu > yYLJsANSKAEkm4AtaAQEEaoUeIFM0gPw4wiN4IjxAKW2oBT6IYmmS7n0moBKIQU9WLT3mAAL > uIBB0KkaqAFT6wCgocC484AZGMHm+5UKaAq+sotdGsQQAEgAyK0UwAQO4AADHAG+gsT/sakX > iLMIZamwD9gkjkgZwBObwAk9YPoDSNg7KjDFoomAtRCdf/iiDLADJRy4S4iC0is9DMiCBLDB > E4g/weGRdmKAP/gMIDwAEzAB6Nk/EfOAD4gBATAEEigAZsSTCIA4GhSoRbgBBpAB7WgAjBAE > OmS+cQwwi+gAmnMPB6iBnvSIeASAkhgEHLCBeym0pkkBRpCBdvwIm2IBB3Aqp+oCJACVQ0go > BYgCTyiBInqAjkAEghQ7AjDIAKgFCeILDkMERQiAiOSAfXi7FaiXZRmBxbEE0roIvIqLp2DJ > jyihDQoBTAQA0ehBtzmEHkhJ0UmB0xQdRLAYNrkSjqCCpYSd/wNAhAGwwSCoNwMInwexg+0p > sghoMaM0vdOoiVgsTApwjhiYgWTEkrlaE7sUghJogQYgIIvoxkGApNnUiAcEiRpwgAYom1Ri > hH7kiBSggxRgHVDqAkVxn6ohhS4YBBboIjy0iH94JW1smhoQBBBYGkQwgdtRBFb6Ax8YAdG6 > GxV4sArgKwWITKsYRDoBAEvwBEt4yH0Im3EqIbGJAQOIgHWxDivbFmH5gJMwACJwsQWRxNrR > tQIjgIGjn89qIgmIgEtgRSspsgDtATizgyBwIUu4nQOAGN5BSUSAAUFSiiHTHqNkAA8oqH/Y > LTZxHkUggTdRBCkCAPuKGj1ggEJoBP/bAgD1aSooYIE9IISYgEeOUM/3wJmbew9SoAH4vAhS > IKrxgKQOUJQu8BnvcIEXsIEDFSqPMIJSaAQWcSoH6ILuKAkHYIFb7AIjIAUT4BXKsYhy+raC > LIAU0ZEIEoAokACI3IeHRBsYCAATWoETvYvAyYIj0jtxkc2vSYEhIACrgICWcS0GKLAjMsik > MtZ/sITJ2BwK0AzdxEEAIEzhoTgyOoFD+A3qWI3aSI0TOIAhoJECYICDOziBEoDqIAErObPC > 9Irg2AAfBYBQMjpG0INCWBOHmqTskxqc0oN9LYSxBIB/oIH5sQgXaBqPqJq1VJ/ls4FCYAHy > xAEL6A6n4i//OqAD+GHLi3iBfGABhSA59kgB+xqVFCAFIggCCXjVcwqQDtkVHA1BBdMRHREX > RTAFVWVEbYmBQIxEFnmW00gAEBwWyihWjFjMCwmBBECEnmGAnxAMzDLWpEJRiUoAovkHg/EA > gcKAIY3C27MSCVAASyACygAzhaAAT/gATyABGMgCqhSCAwgACTiEt11QNsEARWCRCNAMD8CN > E1AA2yu+AUBUAxgFQmgEGWABGaAoSxAE7bg0hfhKFpikL7wI+REfSuoU6fMOSulXj2CBh6UB > C6Ak+GoA8mkBRqCBF6BY0wVQhQABC9gC7/rOVKKBo/Gagy2B34AEJoCEeeHDAosL/wi4mJe1 > ihtbAFNYxLdTqwUggsypBSM5ATuIgBNggAUQogqYQadkHA3QgA/wTAS0CAmABF+akNlsWlU8 > gAU4gBJ4oWZlUsYxLdLDWwXQABjYgNyIWhJYwoKwhCjgKxBggCEgASIYgkOYggPgg9+QxZ3Q > AIbCAKkQABKIgQyoBaZcBBrQgGssBD0QAkubHETIgi5sACPpRhb4Sj0QBFO0gRroyAZoBKdT > n/MphEEYBe+KT/xY4S1QWBawgLe0gIatgdM93QcMCYUwggsghC4ogO6aJLN0L/J4gQphgj84 > ALEd0wNQ2qYIgV75AOC1Crn4MOWYE6sAFmCpChGov4AiAv9mfYrezTIQgIEYmK0WKAdA4KFB > tArpsAhdS8gQOCNPHN9LAYzbmYJyQE9EqIzKOAH0zAJDcK0gwJIs2IAz2gBm7Ue/6QENMDjo > zZ4hKAEJKOQgaFJEOIBgjZOMyYBOlIFFUIQtEAJS+E4ZwAUaQChSsIB7bAxBaIBCsAELKAQZ > voia28KaM68tuJ+SCCAcwAOYGISOIIWtyY+HXSUbYIGeux8WoAF8pFg6yLkx3R+mylhCiJqi > ipoOIA8DEAR4soGeIYVoSIQjmAkBwICk/YnvRQo/VEgd+b//k4tmUo4LUbxgsQoytj8ASKz/ > A5fMepkDYIApAAR9MSFk+a4goOP/FSCtIyAAT+hjS0mZAQaEAziC+CsHNyrgZ82iBZgCNAuA > BNghIeuQhEjWExjgQwjgKXAUki3gDyiHLOiBIGAAIdADXAgAQ7CYKNCpACgEUlgEPWAdM93c > BnABViLmncIBPXCqmOBT+yJHHCgFHFA08eiCC2g6S0pmjjiV/8JmC+CvAhClqHYAmKtmfGxq > 8bTHp7sAmLDhktCDPf0upvqOf7ABLcDdI7gfKJCB7/22bSGAR1gAO6gFhZwBPundfNbnC4EE > H1iACyHjAsBahqQbyBHN5sux+EheHcnOBIGAQYxVhfDeKL5oVQQjhEZoBiibBPA6y2DfOBqC > A7AEBaiM/yzIAg9IWbENMQXAgNv2xUM4AhZRACJ459CLvCMgBAZABJ0SgAMYBSFggX8ApQDo > gRL4ORYwBVxgT44l5p7bg09qhPs5CTrwanUEACMQhBfwajzAAz3wyCpoBPVDoO4SoAlgAT2Q > gUVLJTpwATrwGiPIr0LAg1JYFfniT6O6CBvgmS6QPr5cUCOYAEboAET4XmCBnKcYgQxIgeal > mM9ZTemN7OBtCl86IQO4G0RAvQSoABE4KwLASAGxC7y5EL4DwhQLAUpMgVlLxdVuvkKR7Y0G > BAbgaEJ5ECSHbow4gYObqDeiqQGwgyOIgIqgAMZJ6AMApCkYbdmuEhlsSyGwHP8DYIQSEIIp > iB1E0ANSoBIN6ABSIAEZCNP3WjSSaNg9uGtSiInYZXGOEIStWm+4JHBBUG8c2IPYxYgUKIRC > 2AIEp6Sea48OEGb1aoF7lNyMIGb1a+a7Ti9AFxXvwDMopgAqUARDYLV4PoAYkKAVqAUFgIHN > 0SWChoEToOMIAuMNt2zAqldarBcIoAINWQGkQo3IJBC4swhFuLG1EUgAEXKOkICvPQFESACI > UYAjmILZPgIlJwKvSzsiQfJYVC9LeIAsIBh6wwjLAITtOYDUQO7b8zo72AAWmAIfEIF6uoGG > VYQSKIQS4AyxkIBFYAQHoIFKfi9KKQADMAAbaIii0oP/0OXCBhgESVHdrbpmzy2FioUfOsjq > C7hY/+m5UcCBC9Dlu34BC9gD9LUIPY2aSjGACSDYUhsFTPK5i3g/hWCBoWkqEDiCV4PeCNCC > kixJEziBxa4KcfOAFVEAgl6BBEiAl/0/XvrehvaLdgKBBISBj4tk6SUAymu+Hjh2FLoItPBM > mTkBSPCAEhTyFiCCW7SdiYInA4hjrzuAKQXC2f7tBLFFuFeIKNiJf7i4B4CZO4beBd0/0oES > zwgC7CEEGRACagkAO8AAGbhrBCGFBSABiLIEVYKCG+AQ82hYGng/osKBFxgETeH4PYAJAB95 > jT90in1v9aYDC4DPf3Aqonr4/4SlATrQg0aAAgdKgUGwx4vwFKLaA67ZgkEAR4WQuRIYBEY4 > v3M+IlKYgE45AKGHBBkAgQ1I4xUYMwhggCgoTQKQMXumY14xSYe2BMPSpdsTlnHqiB7wAcbu > ixX7oTSuhQdcBAfL+2dHBCsBCA92PBzAUC5AgUUHGDCUAOAhCEQMTzyMgIgIkSEHDiyw9E+R > HQMPHw6AQYWKBgBETiwyEaQFAAUJYmCweAICoEKEiDAo5PDDBw+FSpD8cCJKhIcdaOCIIhIA > CA1QahhpgAOHjRSCBF0oVerCnkEFALC4UooOHUE19OApZQGthRdy/40EkAKKhQZ59TTYoqcQ > DQuF9P/UqCHIhpEILAalAAFiJIguDQjx3UIjBeQIUGQwggkxC6k/PrpQPfIH0p8/B7oYobIi > xIoVFCJs0BKEwAICBHrMGOF7RIgQvlWk9rHCtwhLhgLUbWEnQBBIxhXVfZjA0IEZ2rUPGKlg > QXACGZ4C0AIJQscI6rO0MACiQPvH1efTf6iBSJCgQYPw7xHgCAMAMqAAZL8wQERKDEDCgAQb > HZBfAAdQMJ8GAVABgwYCKLLIFIooYMcCuSESkwcUdNAIIUEsIAQNDuiHAQtJIaWBQyN1QcgR > FGRRFxRQXNUAZoLQcQGRROIARQt6bPHVBXTcuAeTQ9LxAl11kYKDBRdYQIP/X3p4SUMDjdBQ > WA101EADC6QAAIVcgogExR6j4HDBFlCoOZINXXj2UAtaCWKCEF10wYIJp/0xBA00QGFObLDN > ZggAAeiG2yXBCQfbcQswcFoIuo3QgyV2wJBASgDYQUILB0AAgQpBKEKeAoZo8EEtRZgygynk > lVMBbCEsAEMPnnhyCCQrsAoJan+YYMIQhzjLQKn1ScunIh5Yy18QB3hgQAsnMMTHIntmwQAG > BB5hwgEKMOBgEJ5ASl8LGpAAgwcR/OIDDJZAMIUM0EbqCQA3ypDtFETQQAQGMcTASA0BeKJB > BBPWNUEhiiBCIAAGQMFUAw1sNWSTaHWFlQyUuWUE/xKj7IHDV17RIR+PeoFpQV446MGIVWOS > dmaiHUBFhwtTHnbBKKNYtQUpNkwsSF0gCPKCWgx8AAUjQqR2GgM9KjAApgRQQRsAMKyKGwwh > PGIpAcLFUA6nI6Q9QAE9AEBBAgBIsC0AJ6gAAQEqEBCtJZaksAAEfWjHAXmhqeCDbitU0LcK > kBCwAgGoMcEEMsgkooIJyFI0LegARKBIFB4EAcGDE6rL04B1lXAEcwyYIAAACmFrB+3SKuAB > DLXnF4QQMkyhh9KKBACCHo1oYEgEWmBwBC4HfBCDVDIkgMj181nACAXdZdyFDR1fAIURRKIF > 1wVX0CCDyjhMAAApmWyxB/8eb7VpRHWk8FUzDg3oQcMEoNABGyQqUQ0YBCNA0AIouEAuaQHL > KPQAli1MoDEjmYDSHnKXF0ChC4PABQQUkixIHOIASZnbAii3AuNBSmyrolxwYpM22CDlDyrw > ja8UYQmARYpeEovA2FYlt4wZQgEKCM6qFiCxhxjgA6tKYh9yA4E/5CYExGFCao4gBEiooIsH > IE/opFUAuiniBHaQ2CLKkcY9xYQBCZBAsyiCiAfxB3fTokKJABCFjUBABhyRQANskAAqhI8F > HbDDQ+7GgiN4IAYOY4GeNHACjGVMAYgohCeooIACEDAC/dMSCGpwlrQI6QI1aAELMkGIPcjl > BVb/aUApXmAEI3DlAkwbCSNkwJcL4GAL88MKKTBjA82QogOkgAkpJlCDoL2ADnFqhFX2UCcb > VMkAW4GMADswCCjYAAbRuZoKFJK7f9RiciuAwagA4Im9QcBYjZoccFYgAkT8IW3ACUEUBDBE > EHjgXQHwAAR8sCrJUQEqH6BRCHoDgShEK2MxmNykdCNQxq0gN4c4AiJKdYDFLe4ESwwj6AxA > Hku0oAUlyIIGUkoBepkOEgcggSUUIr0gxCB38ykAFSyxgX9oAAMlnEIhFmoAG+CgAwzQwzFZ > wAi6tEAAN2AB7/gTABZAgQIC8IQELDRIROxBBh5gBA0K0QVG7IFmFvCR//kEYYS0KCUTo3DL > +YZUCjxMoJRdySAASsaXqySPBS1CUn1SkJUaMJAOvRzFIGiAhz3sIZA8wisAOiAowKoEnAeA > AgY8YIMWUCGFurHWAx4QUBVQjqK6iSEERvABKlqqDxpAhAfGogEPJCAAdoiBBOygiMdFLgbc > OmM5RtCbEPRBAIbwj0j6ENHCWcsDQ6jAawhgjupYootdrMAQQardf1hCtohQhHFHdQIPmKCE > MrEEwqwlgCjAbCQ4jZjcFMBHBsjAQxWRTAl6cKFkvOAh8pXBCTCiiGDJ4AYf8AQ6JZYCNBVi > ZGQKjAUWS6S4DKm/ACjAN7bQJFo2EyyEaECHe//ps5g0AppeGkQX1ARAG0C2LjZwAETCFyej > NQAPeijqLQHQAgw2ZwJdgDEAsjCE1EAiCFkrgT8WoQgq2CFtuumBAqDTxdLybYYhmKIVixXD > d33gAXbzQT8tYRcPZKHJUyRA7wKwgQQI1zcBUIAEFBEDQ2ThAwTgGwQiUCUAIEJysSnoSFIQ > hC6yagWU1C5ILbGjC3vgAyQFQAkYMIRCYQgA5ZBeP9k7H0sQSAEbAIAlgoeT94HABj1aDCM0 > sAEPaKADE9CAAj4gAwDvKQVdUMAJNEABRdslRiLTEg3gYoFfMklLFrglC/ZwAVmulUjSxAEd > vLIHQtyJFHv4cRcAeJf/DjTgx++jD4tH8gIcuHVjemAsDRQ4kn90IccPMUIXMAOAIyRCNB9Y > RLsZQcIDhO3OEMCbBrgIgVp8YG9pk+EHzsAqFbT201mAwXKCkAhIlCoCZIbBnVOzAA2A4AO9 > 8c0MvAcViAugAqzC20hIAYkt1yUFh9jb3nqHaERnobt8DoIRqTAARAxhCiZgwA+D0FxEVmcA > zHnIBjRQAkJcQAi4oAEpksliKEQgkHgUgSIYwQIBEIQG84GCII6QlAJYQgKkYAHUhGSBUszp > fHpQGR4u0DGzUrMFDVg2LemwdrBAGwf0u/ZDqOaZFmSbBjYYajLlXZ0sZDAFe3DEKJCQgnOf > /7sB+MOTnubD49BgMQgwogMUsPBzQGAA43cOQXcUEDkCzMAQHoBobggwgBII1G9R9BoAFMEB > RRDABwc4xAdGYgey6wYDJlBB8FNFAJA3FAAxcGIXCXCJuhjABO1cQQzG4l873IS0Ip85SLMg > AQ20CyYFCAADfH6IE3hP0NbiyHTrgpILk90QDHAEDvDQMb/cSSQBVJgdDMA/LAVDeF112MAg > IIJn/EMEyADe5Z3c1QDNoEXRbEEDEJ6xNYlWoIWQgMwF4EG6hc8H7gFmsEC0aAXjTUBJdQAI > 8Nh8CMI/ENUoZIIeGIEFjEIhMJYeHIYD0FINWFh18JjsHAENvIAfEf9BFzzXLUABAwDUnREA > gZQDsgDHAgQB41QZBIhAky2AD+xNblBAChyAIQgdUDThWDiHBljC4xhCCxBBBeTabQjXDIAR > AGyAAHTRecQfnxhHr+xJAMgNIqiAzIGfdrVABHgCA1jCU7RA+jULIowIAOBRoxXL9I1ECyQA > 2dlBFMDABxzAKCwWy5hSt3lGFnSBBwRAANRNwABCEODCCY1EBBTCoo2EBKYFBNIBAbkMHqiS > HqTABNxdkWiJDTgGCJSPyDQAANiAkSQWADBC46UbAPzDBLgAN+lYAA1jy73A240CIWjF29HP > YKiVYJ1Jiz3EMM5RC9jA0wgKA/iDP/xbpI3/jXEUFBGIRqcsHONUDhf5AOOgBgHQTQ8cgbZU > S7WogAeMxAdQgQRMzkECgAdUAD+mlnCBEQhEwQNY38oBmnX4jQpVYqQMUQSwESGGzgkkQAJg > wAluRBCYQkt4AgkYAhF0YrFo5IWdwAkIQBYYgDnEAAR8Ii9pSVp0gQvQIgbo5LuQAiHYAS4s > Qm3BDQWcQCG0lw18BSmVEg2o3d3RASHIDzAG412NBFdMCQe2AA0QSQPUQDJ2wAtMgOFBxQso > ChtlwQSQAszYgB5A3jfQ5Q02wspIE/6AgAskyuVVhyBEgBCcECl8ABkupjtWmcl52QH8AXQF > VAU8TgicQKH4GQGk/0bImcohBIEdIEIUJEAYZhcGKNpppUQAWJcKLMAHrAQDIMJTLAex+EAf > xN99HEACmA7fLBEFEN1IzlwEHIAd2AHMRIBGfAAmJAAgHMICHKIdEIv0VQfXwcQl3EoMcGWU > wEUGIYIMXEIEvAsFJGU5NABDWEICPAcNsFEHKNtZyEWE5cOx/doLjMKSNAl+ZgkOzGIWNJMs > TcmOsQwIxhgLFMJhsCUU1Ac22oUvudUWbAUNwF0vEYJauRINdMF8/AMiAEi4CAIixMANYEQH > QMENyEUNLAIDGAvfiAAV8KOvRI5xrACrWcIfMMHKbSYkzKEBMAB6FJQG2MGF7JMnkFTjUP9A > VBzC4zSaJwRBOURAEDBHFhiCAZgGJCyABwgA68ibBOBcc1BPcM6cJH1AH2if6KwLA5iCOaCn > IjwAbBHLCtDkborZAwgXJphCJtCPVxJJuhmAABBCEQ1RCuCCIRQADVAGKfQAEZDCILQXDawM > k2xF/kFbluSFIHSBhr0FfpqluyljXb2AC/gYDdwYEDajCrJlOUKEIPQJl8wgYnWQBbDPjeEB > ITRCMxmQm1wCFTxAD2zAB2CAIpDCLOUNCSDCIjTTDZQA1BQjKRiLyVlp9CHLCpwNP7qmD5xG > xkGCKaTUAfjAAnAAnyQABGgkIgiABqTQCjDHCQhUbJhOECQAron/2YfYDRMMAQdYxMU0zQcc > 3UgIgL5+aejoJDqggwdopHwtRB+YAgn8gwEMajkQSwikxABQQA/0QAQo5HHMAAdggv3hwBV4 > ZSnsARQoQgJ0ABEYQhSMBaGOCAhEQBcwwAkc02VYySeGohEoI5HMFZa4xV2MEsiUgvqspzle > hg1YwDJ1gSnRwCs+BBL4DFu6W4wJwo4wglsVzSikQApsCSFsgd/hwCjkAx0YkJ5QgCHAwJAy > wjaV2kgoAgwgAmmcwBEkKylgRGkxnAnYqOQIV7YcgkBNShdCALLMYRiqQAb0wBINRKm0IQbc > BgEYgp15gLquwAOsbBAIgJiZitIxgQpk/6tIzYfIVgcJZJe/go4G8IEJAIKqSAwFMAB/HIAp > VCKGZMHxhUAC9EC+SIwn8A2dckBveIAMeMXITFvF/EMNTEAPnBMAaAALlECFKAINfFcBGAAj > kAIFoCK32CceYEkHmuX15sWxtYB/okUzdQEUNMD7hA8pZFsHneVm0YcDXGiidAEYOQAUOEBj > pMAMSoEqQYE1+Q9f4sFifdjXotii0QUIvIAFdEEWzJIBUAAF3I1TOdVWhJ0QMCUWrgCRYev0 > lcPeHMIT9c0fTJEPeCvP+cMCZJLECEAQZBcILEI+9l4UWBLDrUAtdAe4YkAAfJcdSMDxyShQ > OIV3xMCh8Rnohv+utFDAEQDCMQxBfqBKhBSECfRBQRkADBSAAjhnH3BadWjwawiXKXBACPDO > IoDJuRGCffaXDaClBCxAD5CADByBAOSLBRiBJaTiJUWMAliCBkgtIXjtx9ys//YPWjwGCPyD > Y0BGA0BBChSCDRQoqLZXYHXBjUGBfCxQOtrJILhVIyABTNiAK8mA1q7MFjQCDvBMBkVAAtgA > HTTAhYpOtaQQ4fCNB2DAejEAi0BBCQRU7zkOmMmmApCAHX7mCfwTt+7NeZhCQhzCbiQACUyS > SsRke+iaITRODOzJARxcLRgAIqyKClSAAASYE0HA+KWAJ8hNCwTAAqhiXUQAcBJxfRj/gCJk > QRYgggTAQABMzxwfgQQcgQ+YAhUYQhGlax+IAH1EgN8IhwhcggGEygCYAgVAgS9NW4HqGFrG > BAF4AAMIKgVUagEgAsqC2EOcXwS4lV440M363coIjbRMRfIGDPGwgEhKS544gCrjTxZALdVN > AGVAwVjUbAt6EP34XSNoWFiNmF08D5qwAGZggA/ghydIxAkUhDExQgdQIw0cgWJGzgvZQQIo > ph30gAgQQPCRSO/5ALIsAAn83gI8QAR8gADARAksC1AIxG6mzQKInBCkVrRSQSDCHPIpAAhQ > wJvyCZAawnPQhwL4FjtPCylcjAJciALMFiXB7gzUQhRgTzUv/y59uBzf+PBD9MAAEIEMXG+R > dEEhYIYkP4Ry4AIjQNwJ0AGolUoHeO1jKEAEHIEUUOWv2cweSBBKK2gDCMFmQYFfEcK3hc74 > tkBkUIUDiG+26cE2PUQJYChZTsAWLBYe6ERjDQLapYAROIANMMICsEADdIAGLMIhSIBJpsAL > lAAJIAEGnEAEvwABeoIdVAC0zgB6JJQp1EII+MDnHC9ArcDihIAAcDDvvFEUdEcK/FwEKMCi > YdxreCQGFMsIPMIM7ObxrUoFtItDUgeAewAJ0EdKlMAfEMFLJzYTmTIDS4wdzCIAMEAIDFEB > qAoBeNl8SCHjREH3tIARkAINOMLKAP9lWnAg2An2IiToCSACC0SsxExA3NGBEUSZDcjJW8jV > XDFWY03JglZHAeiFcNNAYuVJaYeRq9VAY9SADbAl+IBPB6UlN9GACyRb/jGWXxyQnRjBY1Qq > EdyACr4OInjCCeBFikWB1UYB9MiAWr4AA5BADCALw1npDIiAdohABrTKY1sCIgxa7z2C26CO > lD4EIniZGs0HBUxODNTFUy+fcPSTInARzB3kWieAIqhI0o5ET3XiIiyCiaP4tDAwAExsdRwB > BHhrTPjNbpB6ZHLkCDDAnJSCL81Jk6RdiNFAlbDEeibABOBCD2QBCYxFCkD7BZACQkOBV6J5 > pN7Yhe7ZAXb/22cU6ORhqHEbQQFMhQXIr/iSAvn6+MZ0ULZ1gF+szAFpraLgFbxptx0ogGDJ > bxAwjKIgwvBdWOcsRL80IaKKRi38mweEQAaIgK8EwSKcjgp4AvrxIWz4QArDIgy0AEre1Ou9 > C1QkwFMHxyOsABuat6sHQSIVhDp/X8sJgA/EQA8cgIfzOn1oksnOBwOowAxcGAbsTQh4JJ8Q > QaH4zQgsgNZ6GLRzYDH2rI0pTTlIgAUgAiENAqvdMXuAuy3xCQ34rixZxR93gQtWBwhcqJvg > SSMIQiEkqHHfkvhCAQYxRY9cKNXYgI9D8sroX5r3TwqQRwucySB0QBQEIAAYASP4/+oBJwZD > 6dhCEIEdBMEUZJYCKMIf9EEfCN0CzEAG+MoHEEgUlOQHDISVKRcEeOToSMCn0Uc02/hDWFU5 > mBMBEF0LNIgKHEJtMwRGhIS0HMEJjI5HET28cABtsVEBYBwEhADjRp/Lj4QEHEKh+MCqf7Iq > 4emxCYLTiIzfUVveIEJ0P4QeeICX1dwDOGCRuLY5NtZXPM31NgArLRAB11WagzlATLABgCAA > A3pe4IBSkGFDABEW2nBhgGCHCTQmTOjSwOIEKDZS6MGBYw+NFBpbNIRCY1AXEAkSwEiwiAGL > RV1eALDUw5INKFNKvJggwEMQDxQsffAA6YAPD08/kEhJIf8KwRaeJJQLYWoGAQIVomigAEPA > WEsOCQZYQIGhAgEtjB7AYOdSQRARFAFiEAFAixMZNKAFkOUAW8GHESdO64FKQw0fFBH5s8BQ > EB8EVnxooaEAwSxBTJhoSmDEAUJ4Ro3asgdPKTx0Xrygc6HUBRxb9LR4sIC3DDogBjEwVJAK > AxwXkNNh2OB4KTopLLzY2MBGB0E2uughtAU3DRxGGNrA0aBBCsUAQLBwkLEvFAcpagD4lwLK > SBw0atSg0eAFDRpdaACBoBSyIEgjUgSkYAAHjpCBkRoWKQE8S0iQ4L8jiBCkgyBKYMCDD4iI > IIhDDoDgqVoKJCiBxgZTBIATfJj/YQQCIIDAqQ0CKOAfO1J0qAA7AitoMwA6a+GIAzygyCEB > AaCgKMMaSuGI86isUgAFHMIggb6GgMAUD1SowAcfgjghigBaEGAILBhIAJEeRDhglD0IYQ2H > UhqAAgQjXkDONjpvMASCIEhQgJF86GChERkQpCAGCRrAA7lSBjLIhj0mNcKnjSZowL//Rsmk > kD3G60LPgmrAAUAmFWsBQBqgcME8EOIDwFQbbNAPClIAJIiUj9AjhYUubMioWFImIAGRLmpw > gQ4I+TKABKyG7YCLDvxhpAQBOiDCkwjsGCuGDDLo4QElexiAIBgGUMCTRfoQAIKvKqjAE4Io > GO6wshAj/8EDTwwJQEmHIvAEEQ+CrFLhhc9kyC8iCjpCBVMCCMEDIiQggQIFDIkBNCQUsOQf > ABLAYhQz7vTzghcEIciISPcYhZEYPjjhXgBsKOSC6FaiQQYGWNoD01IsKMgAFiRtGYAJRtpI > oU4z0QOKQXAYlgalU1AVioUUtoEGG1IiqAavJ2BIkAlSoMEBggThOoVhSQEJCkbiJuWEB2ug > owtcEqBIgQROMPQ/DIJQxAgIGIgChizsYDELRVxMIACCosAyiy1JsAQEARgo0UavNijAkgcQ > U4QBNA0YgDOxAuihh8DAjcGQBB5Q0ACKNDiAFCLOWth3KinAwBNFAlAEAyIGJv/lkBkuieFv > gx7QQAMPTFiEoEuoCGCEIbzZojYLLLiAjtoqJaUBAC2BQYMeAr5EkebET8EBUmQQiJRC8GBO > aZxxeqEAr4kFIE9BoQujaADaumABAjbgbOTpQhfCViUD0AA8Bcla2RoiiP0Y4SRQmECBDHAq > AKSgA2Er2AvyYxNEhE1yMDAAI1hQA0Qs4HH+cIoCAmCHkRVEAyT4wL1aYAiKXGJyPcASBg4w > hBiEQAWYIQDN6nIYECCCCB/AgAA84YkeoCMB5mDVYChAhZhssQcwCAADhqCCIEjgd21MTAss > EUdESCCCAFCACZinwxOA8AGKWMAiBOS1N41gAQwYRAP/LEAH2CiyFDQYUANuZ4jAtIADFKCA > BISgMjoYIQG9AwAU9lAKHFhgYBXxFCmENLUtjIIU9IEVgCwgtKYJ4otV4lUK/gGCFLyAP7Vs > QQPGdp0CtCAjcSMICIgFAA0ADiIaIQKWCKIAKiwTACVggQ2MwACiROAfiziEB6JIEANEIQon > SFLrokk6AQTmBEQQziUyoIIVzJMA6kqMLhXQgiGdBwRiSZ8hPhAFRHzAEFBy40HPo4Ep1IIK > djBABLbUlwR4gHQdIEQmUlCAGIxgBqYwhAUEYQRBCGI2W6hUMg2hLgPAgCAPOMIVwkcbIzRM > nHpoDR66wJcBHbILQhJnCsxj/xUA9QwKQEUoAU1Vgwn8oz8uwFUWsINBhvwvghFgQQQkcAJE > dIBYLbiBJ5sUGI1hxwakYIAK7JACEAiiBAtIWJNYSrIoFLQgMFCAIjpTjgNcIjADKFEIQkCA > HnRGmSfAAF4RihbCAsCHRkzsYwUDAkAwtAcCO0GQFOABGKQKCQWSgB1GEFpTkGKkJLUADkah > U2TaQJIG6YEBfhSBUPqJDorwZAqY05qfMYmABiCFArOgB1QKRj0GKaUbKdKCLxITCjVAoVQP > YwAGkEgAB8LVYyYnThZpAAZi7IEnBPCBGJzABiBQAASyaxBJtmCOTlnswbKLCAgsVgEHWMEj > MBOYx/+cgAInEMBxISskT3iABAAOMEKPsAAOoJMCiDWAInCxB65JNws9YKgBjECH8N2GEISI > IK06EFQqGOAfMWgBKQZRG+SUoAdWscBFCqGHAwQhbCnoaV8YMYhM4KCWBfnagQ98BK9AgAjm > AUkA+kA6goiFIQHwRAAkEIAAZE+SGhBsQSTwOgaY4A9qPMEJYBIZRCggAoaNK0EkUKMPCOAB > EfhARAHgCbACmYcCwAAb6ZxY+XIAAEACgARg8D8cMCCZBGGAAmBrhD3RYSRbIMkgVAIbQZDC > EFhiF85SRhuEAQCF5TgE4mQgAIbUQBBK0kAEcIKWFtCgjnluowGIsIJarGD/LQBAlgDKhWZD > mGKayoxCORQRA7Fs4CEsPYG+NICOARABEgwoR+dOnQBFZCELiFhEObLQgk0fM18LsIQHCOAJ > VsXE1Q0BgRYOcIJyu9EGh3htAloMgACUoBBH6AEulNYCBhxhNuLTsB5IhQdCsMAgCggMSWXj > AkYkoAUUELWtMYUcXAjABf7zgA964xIQCGjVUEiJgHDb6qXdeN1thAtgARsDXi1CvEJ8kQhg > boAgTq4AUaDAjtjyZCcZkQNUQIQPGH4XBiwWLTA4M74MERl4w8AwJDh6yQMw55JT6cEsnV5g > skaKwDBiEYBjgBAIkQ/a7sHRF8DDFkiRADvEwHWK/1ikIF5wByJQQQAuAgANJIUcGRAiCwXw > gD8WEIIT7GeoAhIEdVAF3aU1oEdTX1gE+jCDjnLFEylQRAZiEIPOnADmpriEIVgEAEUQWwD+ > 8JgHYsCbGNjhAz7QqVUSk4WHeyYGPWq461oAE8fvHrl2SIkAJmeqgkCBBScohwI6UHY/kQQP > OMhHI8gZAZkrAAZ3QDjLIkACOxBgci3AwRVog4MS2AFcGZhBDHBBBACJBFZAtYBL+nI15dKn > BkHlvcIM4QERmAITpvB/ADIv89QFEWBOBOiqILLAAzAAA76N9QzBiPxoUAwsujAAmvIlvYRE > ETwB3u6vAyXI5uJMAoyA1f8KwgEciSBYYBRaw0/CR2i24GfqyBKCorRGSpkSoA88YQBsAOAI > oaeS4gAWwANwAREeoAdQjAayoD/cA1YG5FWUqsc8UEgSoEdgIAjGRfI6agZ64ANEQHakxxMW > IANEwKCUyQQEQEAKAAY8oA8MwRA2IAsWwQQwQOQQgwiIgAQeEAMZwgAwICqi8A8RgwLsAABC > RKkYAgR+DAAa4TSOY1KYowGOABf+A5oAAAYQIZFosIKy6AER4QhGoQuM4BJCgNY+oAsCo7tw > ZiCy4CMMoAEi6B/oEBDRTDQSAIc2gAFqIfUAawXGULxEYAMeYAMEIAZMQQTCiSDKIQj0Rd48 > IGD/oElEDoASFcO8ToB4JpAg/Cj0ZHEbCcKdDsAGIKkhmKUvCGFOmg9PkMMCUoAuQKABDs3X > sqADZIAGQwoACKxJHkAIpGYQbqAWZOQGKgUAKuuTWMUABsH+uJFgGGAKQgMSDkERIgD1MmBE > fMBEtC8DPKAH2IIA98+ejkmbAqYFSKAWMkAaxSnPQMAoEnIlC+AIFsGDHOIfuiAFDOCiZmtn > wOcCaAADKCJnMECZHEr0GIEeHcADQiBIDKAD9oNUZAAD4G/JQOQISshAZCAWE7IEQiMrD4C9 > UC8GYCACpsAhlcIDZsCeEGHXPK8hjuAoYGARFmAFpK7cUgAC4m0lV9Ik/9ACPlKAEbYg72IK > Oa6ABZSkAQ4AtgyhM6bHOkrLAiDgEXpgJW5lAvSACArhCvKEVRbhDyAhG+imCxgFChPy2Uxg > CELjDxDhRWKgCxsDBI7ABL4pAw6TIAjQFHpAG5vkAD6gRmLg9aZOuvrALoGz0BwCHHFlJVQs > /OgEHSiCBpJE9Hqn7kjtBSxgEebJAxrAATaFBgoBF3DhCAzhgQriBCBhPBkACaYSOBlCAhAB > EUJDCEJDA0DgAzAvBjxSefRvGSVABHqA1/ZQctxSBEyy5BDhEI4RPWVRQw6jU2CluWjANfCA > ThqhBzhAA2jA7rKgZgSAN4IAVhJlBUYAAmrlkf+OIAY6ygBmUjbHExJ8oPEMtAAU4dSO4NAk > IAJyD/VgbrEYB+ZC7yyL8bWWDAaipw09cvcigDcNVBYNQIFi8cSUciO8YwsIwRH0wAA4IAaQ > sCAi4DLuawVohwJwgQFGQAilsQNugCtMQQO2Jpog4Q+6rC6PNPuwlLAyKzUzL70QITVFgOks > QRE+gDfALQEuAd4CYAA4wA7s7kgRderSBj9QyD1UzScaYDVeEAAGoBZkABF65ATuKwRGoAdC > awGacgQYoAMYAhFkIAqKABPMoQNIdYQOYE19wE0NtBYVq2O6UASCxC+eIggXAPCC0AM0VM40 > 4BJMASPJMFGRNc9OYgL/2sY/YjEktKM8BsADZGAKfACaBIA0PJSjFmBQZCAIccEjI4AIGIH/ > LKERpMocTqDLng44XyJjsqchPOFWFeAuYCD/QoBcLCYDeNUfPGBQAoMKZiAIgqAPjDRZEdbV > XIXgVE0kCOGQWEACOiAbVGABJocmbiASowAXGgFKR4EQQgAXaoHXNEABMGERfkYGoOC4FkEF > bgZREQHbNMAScoQ4MM8QSGCJ8nUGSJIkQ4A3fhX1YOASRCADfGARROADWDRhmRbINKAR6NAE > ya4FskAGcIB+hGAKDKkQGAADtmMQBoEFCgEHCmELuFZGOKoNMeEEjsASACwiAxQ4dwhfLIGw > /3ogA0hyBkJABCQPb/k1BGSnDfeTAzigB2bAAw6BCJpHM5q2ceksBQghBVqAgziobaamBw2i > Dw6hEFjg64Tg0x5hCjIBA95mEU6AARiA7IQAC0MrBs5hH/bhHBwiAHxADxFWAQpFYGeAb3c3 > X0NgBszPEPhKRQgXTibSB07gH3rAA6rCcZ0XsgqAEWAlP/zDgwzAAQYhJQpgAVTgAGoAF/yB > noJgFCBgBjTgAraGEBBnDxwhCEJLRmoBE86BA84hABTAMFpgCtKN6BK2AIpxd/v2dw0QT4+R > Y0TAYrr1BGBLBDzgNJ/3gROrBfg3uZTE71TgEJJQDxigRghBCCjTAv9ghQYcQQgWABe2QAj4 > NrRqgX5jV0ZCgC8U4Bf+QSYcV3dFYATEUD8H4HZaZ3gJIgIy9CmKwhMoYnmD4GAhOImBbAN8 > ABLULQXooBBGpRBkQBkZQXK3wBFmLIuzQAOo4IDp9xzOARNqgZAoUQNaC2H/QQKIFuYAWARK > 6X4J4h8iAF9JMgj7Rpli4EPeSon9OMAsoQJUwAeCJAUGgRAWILRGgAhKYAC6YAumIAQ+NmzW > R4wt2RRGYAWOoiBoNmHLYY8IogCyQHX4NwIw1RLswCjJ5SkqrSCWV7P+OJYPLAu412WHzxE8 > 4BFCKwNuYAai4IQXQGYYggosWYz1dgQewQP/UoS7EBYEGGBpHYK9MGCJzA9vQ6AW3BQAnwKa > ZbmbfecDwgQCoOmRp0CRZwAXYqAWOlgIhGAZlamYOQCZV2AUN80AfDRRW0ARAAkxssASoiAD > fvf8rrlcJCD0NAAjM9KbFfqgSEBMKiAou4BO3jKRGeCER8EWhOB3zSFhKKCYsYcKQLoHYmBy > mA5RDSCrygE0WyAA/jmgz09vdRgA5mjJ9rgWNnmhcXphNMAHKmBeSAAAFmE1MjoywE4KMqF8 > Ocr/OOASSMwSxBjANOBKBhI9CyACYEARjpVIrPqAsbBogXcGHsAsFWGHBgwjlSyn0ZpKTqCJ > vKIHFiAIyK4RpsAG/xbhGDLhALBw8vzPFAqXfgFscxAhCPqYG7PgqpGYIEigqwFY8kSACnok > BU4ADf1oPvk3rS0bLRTgMpwotKjVEYx6FBoBL1y6CPwvr0cW9IJkAGDADhBH3dDz1BJDERab > sXvAh0N5cQxgTwE3A/pgSC/7tx0iAdh6nj1UkxFBIAZkBopA8syUtLnimCVPIysLbp+X7nh3 > /xxbsX46AcLQb20TuMH7mDAAAkYRsDJZBBzDDorRHLCHA/Jab/M6jT0hqxMyCygAmiXAExQg > Nc1lbh1iZjPr/Mw6vAk8SkqEuDlVVg0iC2KAIYZ1P2dgASTvZ+HsQukbEB9qeDYg0BzmSv/s > KHXOWrvtAPPw9p4L/MTra545dQREYAAo4K0YBy2kRbNL8gCbJArOxS7XJ0hIYAMoEcwYIgtC > HC38qGcV/MQJPAUOgABGMZMjvBYS5rMEIwWmQBEUQF04ZqpgQCNXEikYggI2HBG+7IsMIAHe > qpRaoKUN0LeRvMAVgAEQHJkf4aw30Ep8GwBzfBtJwEhBIOrwrCEswZ6kyRKyR12ooBkvgc3b > /MT9AgI81LxHgEUE4LDRIn0YAi+2z3Y9UGMUhgImh/oCoIulyehSatFNvSEkIPA4lVPNFwCA > r0oKQADqtmAEQAIKQAHsIG5LrmStQhGuES2owOA8ofFoRwEq+9T/F11e5imTHwG9ya1KssC/ > NjCCqODIS86sykECFAHOzoMCCozTOTmPkX3cCeLbXKc2XWekDYGbD6MF/FuZQqcD8QIvEAE0 > JeoBSEBy8n2ZwGo9yf3f+2IQGyICAlfRFSbWB7vkcu/dBSO/tag2AyBzGmIRBOrYAf7EN+C7 > 63gDQA+hLq0Dx8LiC4JjyMlmsidh/kEsThcRfv3iwRvXKzsCKsd1DsoTvtvxJOABuBkEqMAr > LSmMaMeMqMATjE5yWt7lwRvh0WLS05DbF8YSXvb+XNQDbFcBemD0/nsAtN7gGB7pFz0+ofkE > zqIA0th3Yt3Y76/MTDcGIFIBFEACBPUf/+rW6+m+IQqACHpEA6YMBj7AMEq6jbLAnd5x6hoM > mhQAHU7AdBPA1svd4Ose4N88lP3ZDnzgA7acIobWjVpgRquR8OPdaCwhQHHo8R9fyWNCcTSg > 86fIEECglX/H4aoRFdcNzJc2jBxiAJye9F1eAU6gUNAjANZpXWDg8wuiACwJ7Rue/P7MA3Qd > stwl4VtAfRyjXXX/8dXuAS4B8uLt1sWIA4zO6KLHIXA9SDSgFojN1dan+S2hjwm9+t1/yahg > y4X2+1/cwf1ZD3GkIGpnA3IfstpfMADCAAwNAAoaCECiQMGFDBs6fAgxosSJFCtavIgxo8aN > HDsCMLTAEAUFAP80ULgUwMBCBRxgUChYwJNCAFQsASgQ46XHhy1gSNQAQ6UCKjASqNyJNKnS > pUybOt34AIYlGIaqwqDiKSdDChsEWEqxoSQMnwUVxCDRNEAAiBoUJKBiIKoEgk/r2r2LN2/d > AoYCaDDQgqGlDzML/gtwgogHRQKoNMwS5URhpJbWNgzQw9OGtYos/dMLOrTo0aQ19Lh6msoD > SwU+0G1I6kCQBxFGMmyh6ETgpAF0LgzgsoXKCIpIGz+OPDnHFhQSrKZAwVIWAVkgtkiwoUd2 > mQw9WUYqofjCAj1eA1AgXrn69ezbA4gQ5SIJsgWbKzVwIsLKsA0VkXQPYIAC1gUDWg//KeBb > QSnEtxBQSQ2XngL8MRTBdwNeiGGGFkWRIEMSNqQAg2U5plQBiszUgie7LUTFJRq+CGOMAHxQ > HUQwDLBVAjcFkEAMm1GgQQEtaLBiRi1E8ZpLDXnSg4xOPumeJzZBFACJBfVAQQRXWRIDggFY > 0hkiJyCykYkrUvDAVh5MCWWbbo4WgVYPaaAiTBtISBAJFmbxWRae/IdRFgYWFMGEACgSw2Rv > LsroUwr0kAAFBZjj4kKdwdQDCS+10MNRDlEAg6IUKUAfAJZYmYUdIjbKaqtJmRaDIbXMMEAB > KkG2lgaGNEYFCWlGpGlGai3EVWEB2GEhRS1EoAEIrj7L6gCX/1Ahgimm1JLBAh6MlUAWGihC > gicLhEpBD1bOWSpFBlgSJKg9AFoADBuYd9tDiCxCBL3Q7quhAQNocEkPpswwgwgGW+uBCVkM > QNQDCciLnXQUoIMjW4aOWtlpHZp1LkNZ/HrbCRpEoBu/Jg8IQgKLANCDwSIU7PLA1RrygcdU > zAVAFlNxUJWnDbWwQZELGZDCIiUXlEAPmYJ7iQbeUmBIk1R2XJIiyzIA6Mlaq4ffIYg8QPDL > Yof9QAAKRZH1gdxCRMGgDWmAgdEHBEAqSHZAascCsQoQxQdpL9STvhpsUMAJOm6NuHIlqFBO > D7WIkIHBM2QQgycS1FhQlRNFp4HfD/9RkWxBIBTlbAQfEOCBB4aQRMIGWUDdAgjBPsTwQwUY > FYEAQifOu14tHAGJB9l6EEIGGVi+e0noiMoQeT1h6bNpyStgh6eK+FWZqYYsRIJj/j2UOwlE > /qyTJ273jn5eCWybAAkJKOJ5RAnoC5MEEvQwgCIUAEfFAAoEsBmIIIIsBohLfS6hgA+sqAWG > KIAlKsUQEASBABBYwALsYAjnDKUyBgABh9IHQrzQKSPQgUhnyqGIDXjCIF+6SvIK4r4GkQgo > AkiWJSpjnqEYAgIhWAEBKFiBHxJAWxAQ2aOcFcIkNqUFAvDZQx4wr4LoyonvQUsEECEAASiA > IAbQQJC8yLz/Ry0EBJ0qiB0E4BAQWMIQD5CAJTYQhSgkIAg8FCIFfQABFfjAByqARBAGQz8l > CnIj33JiBFaogQAoInU1DIySblMeAPxDAjCAQBCCIID3UaFF7rNExRoUBU/xiFSJgkg57gYD > CVBAJScIAQFCYME8VkAFeezjIQ6BgQS8cJC8tEgLqEAvCnggCh4IQuqKGQRPJMATqwLAarZi > B0Ug4gBZKMBnYKKAsjUEUoCLgQc2ADKHXPEh+lOAAl53Q0Uc4ABjYtYuewlPijzgNaTywAIg > cMzUBcFvzTnAVap0lWsu5BIbGEDNHmKABFiITjAIWBRg4AlDfNIhGjjB57JWAAkI/8AHGHhn > PD86kXedBwZBuKcHUGdPY7pGdERABEIs8bf62GFbntydQm9DldSN5WINAYHIHIKIKRlAAkE4 > BCQYkAKQKlUjlujeSRdgzHsu4APMjIF5sFaRDVABTdlJQNausxsJle1f1ZyfRK5HLwWcwC1B > 6KMJjrDUuAaKCD24ZwUt+YGV+q8hAtDPRLDCEA1o9ASeitR5kOUQGMS0JAmIQgwOupAITJCP > hzABmeSK2YosggEYuGcQTlAd6kDEE0BSgP80INCCSMAOqRXdIi4LAAmY7QQdKogiJqqm1NFo > IYigYx5vCdvMCjciJIHBB/wKgAQEF3CG4FYAHuAwKiigAP8FyEKX2PLTnFkidzZKWwRIUgBi > FvM/EjgABCDgg1tKYLjsrQgSARAAIqQAEcjNmQeokFqTbNISAvAABVprKZ1ooJMQASZDEOEB > rBngA/okiQY8cIjzqiAIEnhvey8ckQgAorJvVRPzRPeWplIRAG2TInZwK8WgMMQO/3NNFC4Z > BL8qIo94rC+GbyzOP0ACAocQQGFI0EyHiNYSRnEIqaQoANY+5Ia38UBBTpDXqF4vAXbwgQkg > cYAR43jLKQjPBw7h34KsaSJalOSpHBITheAkXUGK12RSNZPBeKAP2jJXBA5gAhMcIJBb7jMi > ACGB+WTRwmn0xCdh6pBgtcADlQL/Suq8GQXMJbdUJICxRQsihCtnuc+clogpKKdlS1lGAUZT > FJ0oYF0F/IMCH1AEERhAXxg8FEhQmygFLAmBlQLgCH/QM587veUC0HEBpggdQ+4HgBIcAQMH > EBoI0AMDDxDhA6u7iTIVMmA43qghFIAxBDyhEkT84Q+HsDGwgc0AJkBCBelBqCIkQIQkG7s+ > xUxAYVKmO8A9BAQCsGQQtpezM/zBB/M+95YZMG4mlGMiJiJpDAxAHIe0gMG1Te56JdLtIPhg > AWySwR9WAEGDd1oDhxD4H1Z2oKa26AFUAJcCDlBfRJgAAi+UANUakoIPWNID31GACQgQcpFz > GuEm+EMJ/yT+vpEEaSEJOEEuGTJzSTcv0hMxyQd84AHzLMIHQRc6jkEQgTz/od2EIntggaKQ > FCjm4g8pClveaAg7xGCmIQiVYWAQAxR7/cYtAAQkDlFGjy3iw0hryyXN/pseiEoBnrCDlKZr > TQrYAQNkkny69t5nRQA6eRJYbkMi4D7Z8rQsSEr0B6gg9ZskQAIM8IQAuo75LUegHGWjgP/O > WcAWZHdO5cCAApAt8Ro2RCB2h0h+jkACj8b+wqumQtM9AX0qQIoIiwDwQvD17hU6ZLMOOXNB > dsdEvS/f4IDpIGAUgIgKQ+SKLSACO8GHAU/1JE3riqgiSPs0T4Rz/PyniPjec/kEMQUqDRI1 > gOEJilUA0XF/WXRz/eeAl9GAglExkmUZ4bEQ12RND6iBEaEBbMKBZaQBDIBc+rOBJVgR7EIR > wKEge4ZER7AIi3AE5maCJlhCFGFYBYEIduASbXMEJcAADDCDQQgTfqEukbQS2JEa2sF2QmiC > oRZY6OCETCiFFtFUU2iFHaEIh3OFW3gRiFBxXAiGDpEAMhiGZYg0l2aGabgQWZB1auiGACAl > b6iGCuABhCeHU9gYd2iGqfKFeiiFAeBkfhiGG3AigsiFi/ZrhmiC1KWIjeiIjwiJkSiJk0iJ > lWiJl4iJmaiJm8iJneiJnwiKoSiKo9gUAQEAOw== > --------------000701070601060606090904-- > > --------------040300030302050604070200-- > > ------------------------------ > > Date: Mon, 8 Feb 2010 13:23:37 -0000 > From: Ian Tickle > Subject: Re: reforigin on 2FKA > > Yes, thanks! I wish I had spotted that before! > > As you say Tables 2.2.3.2 (pp 212-213 in my ed.) & 2.2.3.4 (pp 214-215), > for non-centrosymmetric primitive & centred space groups respectively, > contain all the authoritative information you need to define the allowed > origin shifts (as well as info on semi-invariants etc). I think it > would be useful if all documentation/scripts/programs which claim to > specify alternate origins etc referenced (and of course were consistent > with!) these tables. > > Cheers > > -- Ian > >> -----Original Message----- >> From: George M. Sheldrick [mailto:gsheldr@shelx.uni-ac.gwdg.de] >> Sent: 05 February 2010 23:08 >> To: Ian Tickle >> Cc: CCP4BB@JISCMAIL.AC.UK >> Subject: Re: [ccp4bb] reforigin on 2FKA >> =20 >> =20 >> I have just noticed that there is a definitive table of equivalent >> origins for all 230 space groups in volume B of International >> Tables (in Chapter 2.2 by Carmelo Giacovazzo). This appears to >> agree with Ian's last email in this thread for the space groups >> discussed there. It gives the origins directly rather than the >> Cheshire groups so may be slightly easier to use. >> =20 >> George >> =20 >> Prof. George M. Sheldrick FRS >> Dept. Structural Chemistry, >> University of Goettingen, >> Tammannstr. 4, >> D37077 Goettingen, Germany >> Tel. +49-551-39-3021 or -3068 >> Fax. +49-551-39-22582 >> =20 >> =20 >> On Wed, 27 Jan 2010, Ian Tickle wrote: >> =20 >>> Correction: my apologies, I see now that the table of Cheshire > groups >>> that I referred to originally came from: Hirshfeld (1968), Acta > Cryst. >>> A24, 301-311. I got it from Jorge: it's still good to know that it > has >>> Jorge's seal of approval! >>> >>> Cheers >>> >>> -- Ian >>> >>>> -----Original Message----- >>>> From: owner-ccp4bb@jiscmail.ac.uk >>>> [mailto:owner-ccp4bb@jiscmail.ac.uk] On Behalf Of Ian Tickle >>>> Sent: 27 January 2010 22:25 >>>> To: James Holton; Francois Berenger >>>> Cc: CCP4BB@jiscmail.ac.uk >>>> Subject: RE: [ccp4bb] reforigin on 2FKA >>>> >>>> ... and I was assuming that since it was clear that there are >>>> omissions >>>> for F222 and F23 on the CCP4 'alternate origins' page, that >>>> James' page >>>> was 100% correct! But I think we have both made the same mistake > of >>>> assuming that F222, F23 and F432 all behave identically as >>>> far as origin >>>> shifts are concerned. >>>> >>>> According to this document: >>>> http://www.ccp4.ac.uk/dist/html/cheshirecell.html which I >>>> have no reason >>>> to question since it comes from an excellent authority (Jorge > Navaza), >>>> the Cheshire space group and cell for both F222 and F23 is I > centred >>>> (Immm & Im3m resp) with cell lengths a/2, b/2, c/2. This implies > the >>>> origin shift (1/4,1/4,1/4), and therefore by unit translations in > the >>>> Cheshire lattice (3/4,3/4,3/4) also, is a non-equivalent origin. > For >>>> F432 the Cheshire cell is the same as for F222 & F23 but the > Cheshire >>>> space group is primitive (Pm3m), which implies that (1/4,1/4,1/4) > is >>>> *not* an allowed origin shift, i.e. 'disallowed' in the sense that > you >>>> can't use the same SF calculation formula and still expect to get > the >>>> right answer: if you're willing to use a different formula >>>> then anything >>>> (including completely arbitrary origin shifts, i.e. as in P1) is >>>> allowed! >>>> >>>> So the one redeeming factor from all this is that reforigin at > least >>>> appears to give the right answer. >>>> >>>> Cheers >>>> >>>> -- Ian >>>> >>>>> -----Original Message----- >>>>> From: owner-ccp4bb@jiscmail.ac.uk >>>>> [mailto:owner-ccp4bb@jiscmail.ac.uk] On Behalf Of James Holton >>>>> Sent: 27 January 2010 21:35 >>>>> To: Francois Berenger >>>>> Cc: CCP4BB@jiscmail.ac.uk >>>>> Subject: Re: [ccp4bb] reforigin on 2FKA >>>>> >>>>> Francois Berenger wrote: >>>>>> It correspond to what is found at the end of James Holton's >>>>>> origins.com script >>>>>> http://bl831.als.lbl.gov/~jamesh/pickup/origins.com >>>>>> so I guess it should be correct. >>>>> Uhhh... >>>>>> >>>>>> He also says how he found them: >>>>>> >>>>>> # TABLE OF ALLOWED ORIGIN SHIFTS >>>>>> These origin shifts were determined emprirically using 100 >>>>>> randomly-placed atoms >>>>>> that were shifted around with pdbset and checked with SFALL >>>>> for identical >>>>>> amplitudes to the 0 0 0 origin. They should be correct for >>>>> the CCP4 >>>>>> convention >>>>>> of symmetry. (I.E. R3 and R32 have hexagonal indexing) >>>>>> >>>>> Okay, I just went back to my notes on this. I should admit >>>>> that in my >>>>> completely brain-dead allowed-origin-shift search described > above I >>>>> originally found no "allowed" shifts for F432 (not sure why, >>>>> but maybe >>>>> because it was last on my list). Years later, I think it was >>>>> Peter Zwart >>>>> who pointed out to me that I was missing a few of what ought to > be >>>>> allowed origins. As I recall, at least one of them passed my >>>>> pdbset/sfall test, so I just assumed I must have done >>>> something wrong >>>>> and added everything in the CCP4 document and ITC Vol B to >>>> the list. >>>>> For purposes of the origins.com script, I decided to err on >>>>> the side of >>>>> having it try things that may or may not work. If it finds >>>> a match, >>>>> then great! Right? >>>>> >>>>> Perhaps this was not wise of me. I just tried shifting the >>>> 2fka PDB >>>>> file by "SHIFT FRAC 0.25 0.25 0.25" with pdbset and comparing > the >>>>> resulting Fs from sfall to those of the un-shifted PDB. They >>>>> are ~30% >>>>> different. It could be that this is a bug in sfall or pdbset >>>>> (doubtful), but I would say that pragmatically, this is not >>>>> an "allowed >>>>> origin shift" for F432. However, 0,0,0.5 and 0,0.5,0.5 and all > the >>>>> other half-cell combinations do work! Guess I missed those! >>>>> I have now >>>>> updated my origins.com script. It appears that the allowed > origin >>>>> shifts for F432 and F23 are not the same, as I had >>>> previously thought. >>>>> >>>>>> >>>>>>> plus of course the symmetry-equivalent origins generated >>>>> from these 4 by >>>>>>> the space-group centring (F) translations: >>>>>>> >>>>>>> 0.0000 0.5000 0.5000 >>>>>>> 0.5000 0.0000 0.5000 >>>>>>> 0.5000 0.5000 0.0000 >>>>>> >>>>>> I can see these in syminfo.lib. >>>>>> >>>>>> However, from what you say, I understand that only 2x3 > possible >>>>>> origins with each coordinate being 0 or .5 should be accepted > by >>>>>> reforigin. >>>>>> But in my test it accepted all 8 possible combinations of 0 > and .5 >>>>>> that I artificially introduced in my translated test PDBs: >>>>>> >>>>>> m@myPS:2fka# grep Frac run.log sort uniq >>>>>> Fractional origin shift: 0.0000 0.0000 0.0000 >>>>>> Fractional origin shift: 0.0000 0.0000 0.5000 >>>>>> Fractional origin shift: 0.0000 0.5000 0.0000 >>>>>> Fractional origin shift: 0.0000 0.5000 0.5000 >>>>>> Fractional origin shift: 0.5000 0.0000 0.0000 >>>>>> Fractional origin shift: 0.5000 0.0000 0.5000 >>>>>> Fractional origin shift: 0.5000 0.5000 0.0000 >>>>>> Fractional origin shift: 0.5000 0.5000 0.5000 >>>>>> >>>>>> Should I be worried? >>>>> At this point, I would say no. Reforigin seems to be doing >>>> it right. >>>>> >>>>> I think some of the confusion might be arising because an >>>> "alternate >>>>> origin" and a fractional coordinate shift that gives you the > same >>>>> structure factor amplitudes may or may not be the same thing. > Some >>>>> shifts change the phase, but not the amplitude so whether >>>> or not they >>>>> are "alternate" depends on what you are trying to do. >>>>> >>>>> -James Holton >>>>> MAD Scientist >>>>> >>>>>> >>>>>> Thanks, >>>>>> Francois. >>>>>> >>>>>>> So there will be 12 in all, which I think include the ones > you >>>>>>> mentioned. >>>>>>> >>>>>>> If you're going by >>>>>>> http://www.ccp4.ac.uk/dist/html/alternate_origins.html >>>>> then you should >>>>>>> be aware of a very recent BB discussion in which it was >>>>> pointed out that >>>>>>> the entries for F222, F23, F432 and possibly others are >>>> incomplete. >>>>>>> >>>>>>> Eleanor has given me the task of checking & correcting >>>>> this particular >>>>>>> documentation, until then don't trust it! >>>>>>> >>>>>>> Of course you shouldn't trust reforigin either, just as >>>>> you shouldn't >>>>>>> trust any program until you have verified that the results >>>>> are sensible, >>>>>>> but I think in this particular the fault doesn't lie with >>>>> reforigin. >>>>>>> >>>>>>> Cheers >>>>>>> >>>>>>> -- Ian >>>>>>> >>>>>>>> -----Original Message----- >>>>>>>> From: owner-ccp4bb@jiscmail.ac.uk >>>>> [mailto:owner-ccp4bb@jiscmail.ac.uk] >>>>>>> On >>>>>>>> Behalf Of Francois Berenger >>>>>>>> Sent: 27 January 2010 06:50 >>>>>>>> To: CCP4BB@JISCMAIL.AC.UK >>>>>>>> Subject: reforigin on 2FKA >>>>>>>> >>>>>>>> Hello, >>>>>>>> >>>>>>>> I am playing with ccp4's reforigin to verify some MR > solutions. >>>>>>>> >>>>>>>> If I translate a copy of the pdb.org's PDB 2FKA (from >>>>> spacegroup F432) >>>>>>>> by +/-0.5 fractional in any unit cell direction, then >>>>> reforigin will >>>>>>>> find back this translation and consider it as valid for this >>>>>>> spacegroup. >>>>>>>> But for this spacegroup I should find only (0,0,0) or >>>>> (1/2,1/2,1/2) >>>>>>>> as possible alternate origins. >>>>>>>> >>>>>>>> Does this mean that I can't trust reforigin and that I >>>> must filter >>>>>>>> out its results to retain only the valid ones? >>>>>>>> >>>>>>>> Thanks, >>>>>>>> Francois. >>>>>>> >>>>>>> >>>>>>> >>>>>>> Disclaimer >>>>>>> This communication is confidential and may contain privileged >>>>>>> information intended solely for the named addressee(s). It >>>>> may not be >>>>>>> used or disclosed except for the purpose for which it has >>>>> been sent. >>>>>>> If you are not the intended recipient you must not review, > use, >>>>>>> disclose, copy, distribute or take any action in reliance >>>>> upon it. If >>>>>>> you have received this communication in error, please >>>> notify Astex >>>>>>> Therapeutics Ltd by emailing I.Tickle@astex-therapeutics.com > and >>>>>>> destroy all copies of the message and any attached >>>>> documents. Astex >>>>>>> Therapeutics Ltd monitors, controls and protects all its >>>> messaging >>>>>>> traffic in compliance with its corporate email policy. >>>> The Company >>>>>>> accepts no liability or responsibility for any onward >>>>> transmission or >>>>>>> use of emails and attachments having left the Astex > Therapeutics >>>>>>> domain. Unless expressly stated, opinions in this message >>>>> are those >>>>>>> of the individual sender and not of Astex Therapeutics Ltd. > The >>>>>>> recipient should check this email and any attachments for the >>>>>>> presence of computer viruses. Astex Therapeutics Ltd accepts > no >>>>>>> liability for damage caused by any virus transmitted by >>>>> this email. >>>>>>> E-mail is susceptible to data corruption, interception, >>>>> unauthorized >>>>>>> amendment, and tampering, Astex Therapeutics Ltd only send > and >>>>>>> receive e-mails on the basis that the Company is not >>>>> liable for any >>>>>>> such alteration or any consequences thereof. >>>>>>> Astex Therapeutics Ltd., Registered in England at 436 > Cambridge >>>>>>> Science Park, Cambridge CB4 0QA under number 3751674 >>>>> >>>>> >>>> >>>> >>>> Disclaimer >>>> This communication is confidential and may contain privileged >>>> information intended solely for the named addressee(s). It >>>> may not be used or disclosed except for the purpose for which >>>> it has been sent. If you are not the intended recipient you >>>> must not review, use, disclose, copy, distribute or take any >>>> action in reliance upon it. If you have received this >>>> communication in error, please notify Astex Therapeutics Ltd >>>> by emailing I.Tickle@astex-therapeutics.com and destroy all >>>> copies of the message and any attached documents. >>>> Astex Therapeutics Ltd monitors, controls and protects all >>>> its messaging traffic in compliance with its corporate email >>>> policy. The Company accepts no liability or responsibility >>>> for any onward transmission or use of emails and attachments >>>> having left the Astex Therapeutics domain. Unless expressly >>>> stated, opinions in this message are those of the individual >>>> sender and not of Astex Therapeutics Ltd. The recipient >>>> should check this email and any attachments for the presence >>>> of computer viruses. Astex Therapeutics Ltd accepts no >>>> liability for damage caused by any virus transmitted by this >>>> email. E-mail is susceptible to data corruption, >>>> interception, unauthorized amendment, and tampering, Astex >>>> Therapeutics Ltd only send and receive e-mails on the basis >>>> that the Company is not liable for any such alteration or any >>>> consequences thereof. >>>> Astex Therapeutics Ltd., Registered in England at 436 >>>> Cambridge Science Park, Cambridge CB4 0QA under number 3751674 >>>> >>>> >>> >>> >>> Disclaimer >>> This communication is confidential and may contain privileged >> information intended solely for the named addressee(s). It may not be > used >> or disclosed except for the purpose for which it has been sent. If you > are >> not the intended recipient you must not review, use, disclose, copy, >> distribute or take any action in reliance upon it. If you have > received >> this communication in error, please notify Astex Therapeutics Ltd by >> emailing I.Tickle@astex-therapeutics.com and destroy all copies of the >> message and any attached documents. >>> Astex Therapeutics Ltd monitors, controls and protects all its > messaging >> traffic in compliance with its corporate email policy. The Company > accepts >> no liability or responsibility for any onward transmission or use of >> emails and attachments having left the Astex Therapeutics domain. > Unless >> expressly stated, opinions in this message are those of the individual >> sender and not of Astex Therapeutics Ltd. The recipient should check > this >> email and any attachments for the presence of computer viruses. Astex >> Therapeutics Ltd accepts no liability for damage caused by any virus >> transmitted by this email. E-mail is susceptible to data corruption, >> interception, unauthorized amendment, and tampering, Astex > Therapeutics >> Ltd only send and receive e-mails on the basis that the Company is not >> liable for any such alteration or any consequences thereof. >>> Astex Therapeutics Ltd., Registered in England at 436 Cambridge > Science >> Park, Cambridge CB4 0QA under number 3751674 >>> > > > > Disclaimer > This communication is confidential and may contain privileged information i= > ntended solely for the named addressee(s). It may not be used or disclosed = > except for the purpose for which it has been sent. If you are not the inten= > ded recipient you must not review, use, disclose, copy, distribute or take = > any action in reliance upon it. If you have received this communication in = > error, please notify Astex Therapeutics Ltd by emailing I.Tickle@astex-ther= > apeutics.com and destroy all copies of the message and any attached documen= > ts.=20 > Astex Therapeutics Ltd monitors, controls and protects all its messaging tr= > affic in compliance with its corporate email policy. The Company accepts no= > liability or responsibility for any onward transmission or use of emails a= > nd attachments having left the Astex Therapeutics domain. Unless expressly= > stated, opinions in this message are those of the individual sender and no= > t of Astex Therapeutics Ltd. The recipient should check this email and any = > attachments for the presence of computer viruses. Astex Therapeutics Ltd ac= > cepts no liability for damage caused by any virus transmitted by this email= > . E-mail is susceptible to data corruption, interception, unauthorized amen= > dment, and tampering, Astex Therapeutics Ltd only send and receive e-mails = > on the basis that the Company is not liable for any such alteration or any = > consequences thereof. > Astex Therapeutics Ltd., Registered in England at 436 Cambridge Science Par= > k, Cambridge CB4 0QA under number 3751674 > > ------------------------------ > > Date: Mon, 8 Feb 2010 06:29:05 -0800 > From: Jan Abendroth CCP4bb navigationCCP4bb <-- 1999 <-- November 1999 <-- 30 November 1999 |
|
| ProteinCrystallography.org: Copyright 2006-2010 by Quid United Ltd |